10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☑	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended	March 30, 2024

or

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from                  to

Commission File Number: 000-06217

INTEL CORPORATION

(Exact name of registrant as specified in its charter)

	Delaware		94-1672743
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)
2200 Mission College Boulevard,	Santa Clara,	California	95054-1549
(Address of principal executive offices)			(Zip Code)

(408) 765-8080

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common stock, $0.001 par value	INTC	Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ☑    No  ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  ☑    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	Accelerated filer	Non-accelerated filer	Smaller reporting company	Emerging growth company
☑	¨	¨	☐	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☑

As of April 19, 2024, the registrant had outstanding 4,257 million shares of common stock.

Table of Contents

Organization of Our Form 10-Q

The order and presentation of content in our Form 10-Q differs from the traditional SEC Form 10-Q format. Our format is designed to improve readability and better present how we organize and manage our business. See "Form 10-Q Cross-Reference Index" within Risk Factors and Other Key Information for a cross-reference index to the traditional SEC Form 10-Q format.

We have defined certain terms and abbreviations used throughout our Form 10-Q in "Key Terms" within the Consolidated Condensed Financial Statements and Supplemental Details.

The preparation of our Consolidated Condensed Financial Statements is in conformity with US GAAP. Our Form 10-Q includes key metrics that we use to measure our business, some of which are non-GAAP measures. See "Non-GAAP Financial Measures" within MD&A for an explanation of these measures and why management uses them and believes they provide investors with useful supplemental information.

		Page
Forward-Looking Statements		1
Availability of Company Information		2
A Quarter in Review		3
Consolidated Condensed Financial Statements and Supplemental Details
	Consolidated Condensed Statements of Income	4
	Consolidated Condensed Statements of Comprehensive Income	5
	Consolidated Condensed Balance Sheets	6
	Consolidated Condensed Statements of Cash Flows	7
	Consolidated Condensed Statements of Stockholders' Equity	8
	Notes to Consolidated Condensed Financial Statements	9
	Key Terms	23
Management's Discussion and Analysis (MD&A)
	Segment Trends and Results	24
	Consolidated Condensed Results of Operations	30
	Liquidity and Capital Resources	35
	Non-GAAP Financial Measures	37
Risk Factors and Other Key Information
	Risk Factors	39
	Quantitative and Qualitative Disclosures About Market Risk	39
	Controls and Procedures	39
	Issuer Purchases of Equity Securities	39
	Rule 10b5-1 Trading Arrangements	39
	Disclosure Pursuant to Section 13(r) of the Securities Exchange Act of 1934	40
	Exhibits	41
	Form 10-Q Cross-Reference Index	42

Forward-Looking Statements

This Form 10-Q contains forward-looking statements that involve a number of risks and uncertainties. Words such as "accelerate", "achieve", "aim", "ambitions", "anticipate", "believe", "committed", "continue", "could", "designed", "estimate", "expect", "forecast", "future", "goals", "grow", "guidance", "intend", "likely", "may", "might", "milestones", "next generation", "objective", "on track", "opportunity", "outlook", "pending", "plan", "position", "possible", "potential", "predict", "progress", "ramp", "roadmap", "seek", "should", "strive", "targets", "to be", "upcoming", "will", "would", and variations of such words and similar expressions are intended to identify such forward-looking statements, which may include statements regarding:

•our business plans and strategy and anticipated benefits therefrom, including with respect to our IDM 2.0 strategy, Smart Capital strategy, partnership with Brookfield, internal foundry model, updated reporting structure, and AI strategy;

•projections of our future financial performance, including future revenue, gross margins, capital expenditures, and cash flows;

•projected costs and yield trends;

•future cash requirements, the availability, uses, sufficiency, and cost of capital resources, and sources of funding, including for future capital and R&D investments and for returns to stockholders, such as stock repurchases and dividends, and credit ratings expectations;

•future products, services, and technologies, and the expected goals, timeline, ramps, progress, availability, production, regulation, and benefits of such products, services, and technologies, including future process nodes and packaging technology, product roadmaps, schedules, future product architectures, expectations regarding process performance, per-watt parity, and metrics, and expectations regarding product and process leadership;

•investment plans and impacts of investment plans, including in the US and abroad;

•internal and external manufacturing plans, including future internal manufacturing volumes, manufacturing expansion plans and the financing therefor, and external foundry usage;

•future production capacity and product supply;

•supply expectations, including regarding constraints, limitations, pricing, and industry shortages;

•plans and goals related to Intel's foundry business, including with respect to anticipated customers, future manufacturing capacity and service, technology, and IP offerings;

•expected timing and impact of acquisitions, divestitures, and other significant transactions, including the sale of our NAND memory business;

•expected completion and impacts of restructuring activities and cost-saving or efficiency initiatives;

•future social and environmental performance goals, measures, strategies, and results;

•our anticipated growth, future market share, and trends in our businesses and operations;

•projected growth and trends in markets relevant to our businesses;

•anticipated trends and impacts related to industry component, substrate, and foundry capacity utilization, shortages, and constraints;

•expectations regarding government incentives;

•future technology trends and developments, such as AI;

•future macro environmental and economic conditions;

•geopolitical tensions and conflicts and their potential impact on our business;

•tax- and accounting-related expectations;

•expectations regarding our relationships with certain sanctioned parties; and

•other characterizations of future events or circumstances.

Such statements involve many risks and uncertainties that could cause our actual results to differ materially from those expressed or implied, including those associated with:

•the high level of competition and rapid technological change in our industry;

•the significant long-term and inherently risky investments we are making in R&D and manufacturing facilities that may not realize a favorable return;

•the complexities and uncertainties in developing and implementing new semiconductor products and manufacturing process technologies;

•our ability to time and scale our capital investments appropriately and successfully secure favorable alternative financing arrangements and government grants;

•implementing new business strategies and investing in new businesses and technologies;

•changes in demand for our products;

•macroeconomic conditions and geopolitical tensions and conflicts, including geopolitical and trade tensions between the US and China, the impacts of Russia's war on Ukraine, tensions and conflict affecting Israel and the Middle East, and rising tensions between mainland China and Taiwan;

•the evolving market for products with AI capabilities;

1

•our complex global supply chain, including from disruptions, delays, trade tensions and conflicts, or shortages;

•product defects, errata and other product issues, particularly as we develop next-generation products and implement next-generation manufacturing process technologies;

•potential security vulnerabilities in our products;

•increasing and evolving cybersecurity threats and privacy risks;

•IP risks including related litigation and regulatory proceedings;

•the need to attract, retain, and motivate key talent;

•strategic transactions and investments;

•sales-related risks, including customer concentration and the use of distributors and other third parties;

•our significantly reduced return of capital in recent years;

•our debt obligations and our ability to access sources of capital;

•complex and evolving laws and regulations across many jurisdictions;

•fluctuations in currency exchange rates;

•changes in our effective tax rate;

•catastrophic events;

•environmental, health, safety, and product regulations;

•our initiatives and new legal requirements with respect to corporate responsibility matters; and

•other risks and uncertainties described in this report, our 2023 Form 10-K and our other filings with the SEC.

Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Readers are urged to carefully review and consider the various disclosures made in this Form 10-Q and in other documents we file from time to time with the SEC that disclose risks and uncertainties that may affect our business.

Unless specifically indicated otherwise, the forward-looking statements in this Form 10-Q do not reflect the potential impact of any divestitures, mergers, acquisitions, or other business combinations that have not been completed as of the date of this filing. In addition, the forward-looking statements in this Form 10-Q are based on management's expectations as of the date of this filing, unless an earlier date is specified, including expectations based on third-party information and projections that management believes to be reputable. We do not undertake, and expressly disclaim any duty, to update such statements, whether as a result of new information, new developments, or otherwise, except to the extent that disclosure may be required by law.

Availability of Company Information

We use our Investor Relations website, www.intc.com, as a routine channel for distribution of important, and often material, information about us, including our quarterly and annual earnings results and presentations, press releases, announcements, information about upcoming webcasts, analyst presentations, and investor days, archives of these events, financial information, corporate governance practices, and corporate responsibility information. We also post our filings on this website the same day they are electronically filed with, or furnished to, the SEC, including our annual and quarterly reports on Forms 10-K and 10-Q and current reports on Form 8-K, our proxy statements, and any amendments to those reports. All such information is available free of charge. Our Investor Relations website allows interested persons to sign up to automatically receive e-mail alerts when we post financial information and issue press releases, and to receive information about upcoming events. We encourage interested persons to follow our Investor Relations website in addition to our filings with the SEC to timely receive information about the company.

Intel, the Intel logo, Intel Core, and Altera are trademarks of Intel Corporation or its subsidiaries in the US and/or other countries.

* Other names and brands may be claimed as the property of others.

2

A Quarter in Review

Total revenue of $12.7 billion was up $1.0 billion or 9% from Q1 2023, as CCG revenue increased 31%, DCAI revenue increased 5%, and NEX revenue decreased 8%. CCG revenue increased primarily due to higher notebook and desktop volumes as customer inventory levels normalized compared to higher levels in Q1 2023. DCAI revenue increased due to higher server ASPs primarily due to a lower mix of hyperscale customer-related revenue and a higher mix of high core count products, partially offset by lower server volume due to lower demand in a competitive environment and a higher mix of high core count products. NEX revenue decreased primarily due to 5G customers tempering purchases to reduce existing inventories, partially offset by higher Edge and Network revenue. Altera, an Intel Company (previously Intel's Programmable Solutions Group) and Mobileye revenue decreased as customers tempered purchases to reduce existing inventories.

Revenue	Gross Margin	Diluted EPS attributable to Intel	Cash Flows
■ GAAP $B	■ GAAP ■ Non-GAAP	■ GAAP ■ Non-GAAP	■ Operating Cash Flow $B ■ Adjusted Free Cash Flow $B

$12.7B	41.0%	45.1%	$(0.09)	$0.18	$(1.2)B	$(6.2)B
GAAP	GAAP	non-GAAP1	GAAP	non-GAAP1	GAAP	non-GAAP1
Revenue up $1.0B or 9% from Q1 2023	Gross margin up 6.8 ppts from Q1 2023	Gross margin up 6.7 ppts from Q1 2023	Diluted EPS attributable to Intel up $0.57 or 86% from Q1 2023	Diluted EPS attributable to Intel up $0.22 from Q1 2023	Operating cash flow up $0.6B or 31% from Q1 2023	Adjusted free cash flow up $2.6B or 30% from Q1 2023
Higher CCG revenue.	Higher GAAP gross margin from higher revenue and lower period charges, partially offset by higher unit cost.		Higher GAAP EPS attributable to Intel from higher gross margin and a tax benefit compared to a tax expense in Q1 2023, partially offset by higher operating expenses.		Lower cash used for operating activities driven primarily by a reduced net operating loss, partially offset by certain cash unfavorable changes in working capital.

Key Developments

▪We launched Intel Foundry as a more sustainable systems foundry business designed for the AI era and announced an expanded process roadmap, which includes evolutions for Intel 3, Intel 18A, and Intel 14A process technologies.

▪The U.S. Department of Commerce has proposed up to $8.5 billion in direct funding and to make up to $11.0 billion in loans available under the CHIPS and Science Act to help advance our manufacturing and research and development projects at sites in Arizona, New Mexico, Ohio, and Oregon.

▪We launched Altera® as a new standalone FPGA company, in order to deliver programmable solutions and accessible AI across a broad range of applications in the cloud, network, and edge markets.

▪We opened Fab 9 in New Mexico, producing the world's most advanced packaging solutions at scale.

1 See "Non-GAAP Financial Measures" within MD&A.

A Quarter in Review 3

Consolidated Condensed Statements of Income

	Three Months Ended
(In Millions, Except Per Share Amounts; Unaudited)	Mar 30, 2024		Apr 1, 2023
Net revenue	$	12,724	$	11,715
Cost of sales	7,507		7,707
Gross margin	5,217		4,008
Research and development	4,382		4,109
Marketing, general, and administrative	1,556		1,303
Restructuring and other charges	348		64
Operating expenses	6,286		5,476
Operating income (loss)	(1,069)		(1,468)
Gains (losses) on equity investments, net	205		169
Interest and other, net	145		141
Income (loss) before taxes	(719)		(1,158)
Provision for (benefit from) taxes	(282)		1,610
Net income (loss)	(437)		(2,768)
Less: Net income (loss) attributable to non-controlling interests	(56)		(10)
Net income (loss) attributable to Intel	$	(381)	$	(2,758)
Earnings (loss) per share attributable to Intel—basic	$	(0.09)	$	(0.66)
Earnings (loss) per share attributable to Intel—diluted	$	(0.09)	$	(0.66)
Weighted average shares of common stock outstanding:
Basic	4,242		4,154
Diluted	4,242		4,154

         

See accompanying notes.

Financial Statements   Consolidated Condensed Statements of Income 4

Consolidated Condensed Statements of Comprehensive Income

	Three Months Ended
(In Millions; Unaudited)	Mar 30, 2024		Apr 1, 2023
Net income (loss)	$	(437)	$	(2,768)
Changes in other comprehensive income (loss), net of tax:
Net unrealized holding gains (losses) on derivatives	(328)		142
Actuarial valuation and other pension benefits (expenses), net	—		1
Translation adjustments and other	1		—
Other comprehensive income (loss)	(327)		143
Total comprehensive income (loss)	(764)		(2,625)
Less: comprehensive income (loss) attributable to non-controlling interests	(56)		(10)
Total comprehensive income (loss) attributable to Intel	$	(708)	$	(2,615)

See accompanying notes.

Financial Statements   Consolidated Condensed Statements of Comprehensive Income 5

Consolidated Condensed Balance Sheets

(In Millions; Unaudited)	Mar 30, 2024		Dec 30, 2023
Assets
Current assets:
Cash and cash equivalents	$	6,923	$	7,079
Short-term investments	14,388		17,955
Accounts receivable, net	3,323		3,402
Inventories	11,494		11,127
Other current assets	6,480		3,706
Total current assets	42,608		43,269
Property, plant, and equipment, net of accumulated depreciation of $99,315 ($98,010 as of December 30, 2023)	99,924		96,647
Equity investments	6,139		5,829
Goodwill	27,440		27,591
Identified intangible assets, net	4,675		4,589
Other long-term assets	11,947		13,647
Total assets	$	192,733	$	191,572
Liabilities and stockholders’ equity
Current liabilities:
Short-term debt	$	4,581	$	2,288
Accounts payable	8,559		8,578
Accrued compensation and benefits	2,506		3,655
Income taxes payable	346		1,107
Other accrued liabilities	11,221		12,425
Total current liabilities	27,213		28,053
Debt	47,869		46,978
Other long-term liabilities	6,895		6,576
Contingencies (Note 13)
Stockholders’ equity:
Common stock and capital in excess of par value, 4,257 issued and outstanding (4,228 issued and outstanding as of December 30, 2023)	38,291		36,649
Accumulated other comprehensive income (loss)	(542)		(215)
Retained earnings	68,224		69,156
Total Intel stockholders' equity	105,973		105,590
Non-controlling interests	4,783		4,375
Total stockholders' equity	110,756		109,965
Total liabilities and stockholders’ equity	$	192,733	$	191,572

        

See accompanying notes.

Financial Statements   Consolidated Condensed Balance Sheets 6

Consolidated Condensed Statements of Cash Flows

	Three Months Ended
(In Millions; Unaudited)	Mar 30, 2024		Apr 1, 2023
Cash and cash equivalents, beginning of period	$	7,079	$	11,144
Cash flows provided by (used for) operating activities:
Net income (loss)	(437)		(2,768)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation	2,200		1,901
Share-based compensation	1,179		739
Restructuring and other charges	348		55
Amortization of intangibles	351		465
(Gains) losses on equity investments, net	(208)		(167)
Changes in assets and liabilities:
Accounts receivable	80		286
Inventories	(366)		231
Accounts payable	(386)		(771)
Accrued compensation and benefits	(1,289)		(1,560)
Income taxes	(591)		1,344
Other assets and liabilities	(2,104)		(1,540)
Total adjustments	(786)		983
Net cash provided by (used for) operating activities	(1,223)		(1,785)
Cash flows provided by (used for) investing activities:
Additions to property, plant, and equipment	(5,970)		(7,413)
Proceeds from capital-related government incentives	592		—
Purchases of short-term investments	(6,460)		(16,132)
Maturities and sales of short-term investments	9,598		14,173
Other investing	(323)		851
Net cash provided by (used for) investing activities	(2,563)		(8,521)
Cash flows provided by (used for) financing activities:
Issuance of commercial paper, net of issuance costs	793		—
Repayment of commercial paper	—		(2,930)
Payments on finance leases	—		(15)
Partner contributions	423		449
Issuance of long-term debt, net of issuance costs	2,537		10,968
Proceeds from sales of common stock through employee equity incentive plans	626		659
Payment of dividends to stockholders	(529)		(1,512)
Other financing	(220)		(225)
Net cash provided by (used for) financing activities	3,630		7,394
Net increase (decrease) in cash and cash equivalents	(156)		(2,912)
Cash and cash equivalents, end of period	$	6,923	$	8,232
Supplemental disclosures:
Acquisition of property, plant, and equipment included in accounts payable and accrued liabilities	$	5,167	$	4,711
Cash paid during the period for:
Interest, net of capitalized interest	$	540	$	239
Income taxes, net of refunds	$	315	$	267

See accompanying notes.

Financial Statements   Consolidated Condensed Statements of Cash Flows 7

Consolidated Condensed Statements of Stockholders' Equity

(In Millions, Except Per Share Amounts; Unaudited)	Common Stock and Capital in Excess of Par Value			Accumulated Other Comprehensive Income (Loss)		Retained Earnings		Non-Controlling Interests		Total
	Shares	Amount
Three Months Ended
Balance as of December 30, 2023	4,228	$	36,649	$	(215)	$	69,156	$	4,375	$	109,965
Net income (loss)	—	—		—		(381)		(56)		(437)
Other comprehensive income (loss)	—	—		(327)		—		—		(327)
Net proceeds from partner contributions	—	—		—		—		423		423
Employee equity incentive plans and other	32	626		—		—		—		626
Share-based compensation	—	1,138		—		—		41		1,179
Restricted stock unit withholdings	(3)	(122)		—		(22)		—		(144)
Cash dividends declared ($0.13 per share of common stock)	—	—		—		(529)		—		(529)
Balance as of March 30, 2024	4,257	$	38,291	$	(542)	$	68,224	$	4,783	$	110,756
Balance as of December 31, 2022	4,137	$	31,580	$	(562)	$	70,405	$	1,863	$	103,286
Net income (loss)	—	—		—		(2,758)		(10)		(2,768)
Other comprehensive income (loss)	—	—		143		—		—		143
Net proceeds from partner contributions	—	—		—		—		449		449
Employee equity incentive plans and other	36	659		—		—		—		659
Share-based compensation	—	697		—		—		42		739
Restricted stock unit withholdings	(2)	(107)		—		38		—		(69)
Cash dividends declared ($0.49 per share of common stock)	—	—		—		(2,036)		—		(2,036)
Balance as of April 1, 2023	4,171	$	32,829	$	(419)	$	65,649	$	2,344	$	100,403

See accompanying notes.

Financial Statements   Consolidated Condensed Statements of Stockholders' Equity 8

Notes to Consolidated Condensed Financial Statements

Note 1 : Basis of Presentation

We prepared our interim Consolidated Condensed Financial Statements that accompany these notes in conformity with US GAAP, consistent in all material respects with those applied in our 2023 Form 10-K.

We have made estimates and judgments affecting the amounts reported in our Consolidated Condensed Financial Statements and the accompanying notes. The actual results that we experience may differ materially from our estimates. The interim financial information is unaudited, and reflects all normal adjustments that are, in our opinion, necessary to provide a fair statement of results for the interim periods presented. This report should be read in conjunction with our 2023 Form 10-K where we include additional information on our critical accounting estimates, policies, and the methods and assumptions used in our estimates.

Note 2 : Operating Segments

We previously announced the implementation of our internal foundry operating model, which took effect in the first quarter of 2024, and creates a foundry relationship between our Intel Products business (collectively CCG, DCAI, and NEX) and our Intel Foundry business. Intel Products consists substantially of design and development of CPUs and related solutions for third party customers. Intel Foundry consists substantially of process engineering, manufacturing, and foundry services groups that provide manufacturing, test, and assembly services to our Intel Products business and to third party customers. Both businesses utilize marketing, sales, and other support functions.

Our internal foundry model is a key component of our strategy and is designed to reshape our operational dynamics and drive greater transparency, accountability, and focus on costs and efficiency. We also previously announced our intent to operate Altera, an Intel Company (previously Intel's Programmable Solutions Group), as a standalone business, with segment reporting beginning in the first quarter of 2024. Altera was previously included in our DCAI segment results. As a result of these changes, we modified our segment reporting in the first quarter of 2024 to align to this new operating model. All prior period segment data has been retrospectively adjusted to reflect the way our Chief Operating Decision Maker (CODM) internally receives information and manages and monitors our operating segment performance starting in fiscal year 2024. There are no changes to our consolidated financial statements for any prior periods.

We organize our business as follows:

▪Intel Products:

▪Client Computing Group (CCG)

▪Data Center and AI (DCAI)

▪Network and Edge (NEX)

▪Intel Foundry

▪All other

▪Altera

▪Mobileye

▪Other

CCG, DCAI, and Intel Foundry qualify as reportable operating segments. NEX, Altera, and Mobileye do not qualify as reportable operating segments; however, we have elected to disclose their results. When we enter into federal contracts, they are aligned to the sponsoring operating segment.

The accounting policies for our segment reporting are the same for Intel as a whole. A summary of the basis for which we report our operating segment revenues and operating margin is as follows:

Intel Products: CCG, DCAI, and NEX

▪Segment revenue: consists of revenues from third party customers. The Intel Products operating segments represent a substantial majority of Intel consolidated revenue and are derived from our principal products that incorporate various components and technologies, including a microprocessor and chipset, a stand-alone SoC, or a multichip package, which are based on Intel architecture.

▪Segment expenses: consists of intersegment charges for product manufacturing and related services from Intel Foundry, external foundry and other manufacturing, product development costs, allocated expenses as described below, and direct operating expenses.

Financial Statements  Notes to Financial Statements 9

Intel Foundry

▪Segment revenue: consists substantially of intersegment product and services revenue for wafer fabrication and related products and services sold to Intel Products, Altera, and certain other Intel internal businesses. We recognize intersegment revenue when we satisfy performance obligations as evidenced by the transfer of control of Intel Foundry products and services to the Intel Products businesses, which is generally at the completion of wafer sorting and at the completion of assembly and test services. Intersegment sales are recorded at prices that are intended to approximate market pricing. Intel Foundry also includes certain third party foundry and assembly and test revenues from external customers that were $27 million in first three months of 2024 and $118 million in the first three months of 2023.

▪Segment expenses: consists of direct expenses for technology development, product manufacturing and services provided by Intel Foundry to internal and external customers, allocated expenses as described below, and direct operating expenses. Direct expenses for product manufacturing includes excess capacity charges that were previously allocated primarily to CCG, DCAI, and NEX.

All other: Altera & Mobileye

▪Segment revenue: consists of product revenues from third party customers. Altera revenue is derived from programmable semiconductors, primarily FPGAs, CPLDs, acceleration platforms, software, IP, and related products. Mobileye revenue is derived from advanced driver-assistance systems (ADAS) and autonomous driving technologies and solutions.

▪Segment expenses: Altera expenses consist of intersegment charges for product manufacturing and related services from Intel Foundry, third party manufacturing, allocated expenses as described below, and direct operating expenses. Mobileye expenses consists of third party direct expenses for product manufacturing and related services for the manufacturing of Mobileye products and direct operating expenses.

Our "all other" category also consists of "other", which includes:

▪results of operations from non-reportable segments not otherwise presented, and from start-up businesses that support our initiatives; and

▪historical results of operations from divested businesses.

We allocate operating expenses from our sales and marketing group to the Intel Products operating segments, and allocate operating expenses from our finance and administration groups to all of our operating segments, except Mobileye. Previously, operating expense from all of these groups as well as manufacturing and engineering, were generally allocated to all the operating segments, except Mobileye.

We estimate that the substantial majority of our consolidated depreciation expense was incurred by Intel Foundry in the first three months of 2024 and in the first three months of 2023. Intel Foundry depreciation expense is substantially included in overhead cost pools and then combined with other costs, and subsequently absorbed into inventory as each product passes through the manufacturing process and is sold to Intel Products and other customers. As a result, it is impractical to determine the total depreciation expense included as a component of each Intel Products operating segment's operating income (loss) results.

We do not allocate to our operating segments corporate operating expenses that primarily consist of:

▪restructuring and other charges;

▪share-based compensation;

▪certain impairment charges; and

▪certain acquisition-related costs, including amortization and any impairment of acquisition-related intangibles and goodwill.

We do not allocate to our operating segments non-operating items such as:

▪gains and losses from equity investments;

▪interest and other income; and

▪income taxes.

The CODM, who is our CEO, allocates resources to and assesses the performance of each operating segment using information about the operating segment's revenue and operating income (loss). Although the CODM uses operating income (loss) to evaluate the segments, operating costs included in one segment may benefit other segments. The measures regularly provided to and used by our CODM under our new operating model continue to evolve; currently, our CODM does not regularly review or receive discrete asset information by segment.

Intersegment eliminations: Intersegment sales and related gross margin on inventory recorded at the end of the period or sold through to third party customers is eliminated for consolidation purposes. The Intel Products operating segments and Intel Foundry are meant to reflect separate fabless semiconductor and foundry companies. Thus certain intersegment activity is captured within the intersegment eliminations upon consolidation and presented at the Intel consolidated level. This activity primarily relates to inventory reserves which are determined and recorded based on our accounting policies for Intel as a whole, but are only recorded by the Intel Products operating segments upon transfer of inventory from Intel Foundry. If a reserve is identified prior to the related inventory transferring to Intel Products, that reserve is presented as activity within the intersegment eliminations.

Financial Statements  Notes to Financial Statements 10

Reporting units and goodwill reallocation: As a result of modifying our segment reporting in the first quarter of 2024, we reallocated goodwill among our affected reporting units on a relative fair value basis. We performed a quantitative goodwill impairment assessment for each of our reporting units immediately before and after our business reorganization. We concluded based on our pre-reorganization impairment test that goodwill was not impaired. As a result of our post-reorganization impairment test, we recognized a non-cash goodwill impairment loss of $222 million in the first three months of 2024 related to our new Intel Foundry reporting unit as the estimated fair value of the new reporting unit was lower than the assigned carrying value, which now includes substantially all of our allocated property, plant, and equipment. The Intel Foundry reporting unit has no remaining goodwill. The fair value substantially exceeded the carrying value for all remaining reporting units tested as part of our post-reorganization impairment test.

Operating segment and consolidated net revenue and operating income (loss) for each period were as follows:

	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Operating segment revenue:
Intel Products:
Client Computing Group
Desktop	$	2,461	$	1,879
Notebook	4,681		3,407
Other	391		481
	7,533		5,767
Data Center and AI	3,036		2,901
Network and Edge	1,364		1,489
Total Intel Products revenue	$	11,933	$	10,157
Intel Foundry	$	4,369	$	4,831
All other
Altera	342		816
Mobileye	239		458
Other	194		166
Total all other revenue	775		1,440
Total operating segment revenue	$	17,077	$	16,428
Intersegment eliminations	(4,353)		(4,713)
Total net revenue	$	12,724	$	11,715
Segment operating income (loss):
Intel Products:
Client Computing Group	$	2,645	$	1,180
Data Center and AI	482		22
Network and Edge	184		(69)
Total Intel Products operating income (loss)	$	3,311	$	1,133
Intel Foundry	$	(2,474)	$	(2,360)
All Other
Altera	(39)		290
Mobileye	(68)		123
Other	(105)		(66)
Total all other operating income (loss)	(212)		347
Total segment operating income (loss)	$	625	$	(880)
Intersegment eliminations	494		456
Corporate unallocated expenses	(2,188)		(1,044)
Total operating income (loss)	$	(1,069)	$	(1,468)

Financial Statements  Notes to Financial Statements 11

Corporate Unallocated Expenses

Corporate unallocated expenses represent costs incurred that are not directly attributed to an operating segment. The nature of these expenses may vary, but primarily consist of restructuring and other charges, share-based compensation, certain impairment charges, and certain acquisition-related costs.

	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Acquisition-related adjustments	$	(265)	$	(371)
Share-based compensation	(1,179)		(739)
Restructuring and other charges	(348)		(64)
Other	(396)		130
Total corporate unallocated expenses	$	(2,188)	$	(1,044)

Note 3 : Non-Controlling Interests

	Mar 30, 2024				Dec 30, 2023
(In Millions)	Non-Controlling Interests		Non-Controlling Ownership %		Non-Controlling Interests		Non-Controlling Ownership %
Arizona Fab LLC	$	2,760	49	%	$	2,359	49	%
Mobileye	1,854		12	%	1,838		12	%
IMS Nanofabrication	169		32	%	178		32	%
Non-controlling interests	$	4,783			$	4,375

Semiconductor Co-Investment Program

In 2022, we closed a transaction with Brookfield Asset Management (Brookfield) resulting in the formation of Arizona Fab LLC (Arizona Fab). We consolidate the results of Arizona Fab, a VIE, into our consolidated financial statements because we are the primary beneficiary. Generally, contributions will be made to, and distributions will be received from Arizona Fab based on both parties' proportional ownership. We will be the sole operator and main beneficiary of two new chip factories that will be constructed by Arizona Fab, and we will have the right to purchase 100% of the related factory output. Once production commences, we will be required to operate Arizona Fab at minimum production levels measured in wafer starts per week and will be required to limit excess inventory held on site or we will be subject to certain penalties.

We have an unrecognized commitment to fund our respective share of the total construction costs of Arizona Fab of $29.0 billion.

As of March 30, 2024, substantially all of the assets of Arizona Fab consisted of property, plant, and equipment. The assets held by Arizona Fab, which can be used only to settle obligations of the VIE and are not available to us, were $5.6 billion as of March 30, 2024 ($4.8 billion as of December 30, 2023).

Mobileye

In 2022, Mobileye completed its IPO and certain other equity financing transactions. During 2023, we converted 38.5 million of our Mobileye Class B shares into Class A shares, representing 5% of Mobileye's outstanding capital stock, and subsequently sold the Class A shares for $42 per share as part of a secondary offering, receiving net proceeds of $1.6 billion and increasing our capital in excess of par value by $663 million, net of tax. We continue to consolidate the results of Mobileye into our consolidated financial statements.

IMS Nanofabrication

In 2023, we closed agreements to sell a combined 32% minority stake in our IMS business, a business within our Intel Foundry operating segment —including a 20% stake to Bain Capital and a 10% stake to Taiwan Semiconductor Manufacturing Company. Net proceeds resulting from the minority stake sales totaled $1.4 billion, and our capital in excess of par value increased by $958 million, net of tax. We continue to consolidate the results of IMS into our consolidated financial statements.

Financial Statements  Notes to Financial Statements 12

Note 4 : Earnings (Loss) Per Share

We computed basic earnings (loss) per share of common stock based on the weighted average number of shares of common stock outstanding during the period. We computed diluted earnings (loss) per share of common stock based on the weighted average number of shares of common stock outstanding plus potentially dilutive shares of common stock outstanding during the period.

	Three Months Ended
(In Millions, Except Per Share Amounts)	Mar 30, 2024		Apr 1, 2023
Net income (loss)	$	(437)	$	(2,768)
Less: Net income (loss) attributable to non-controlling interests	(56)		(10)
Net income (loss) attributable to Intel	(381)		(2,758)
Weighted average shares of common stock outstanding—basic	4,242		4,154
Weighted average shares of common stock outstanding—diluted	4,242		4,154
Earnings (loss) per share attributable to Intel—basic	$	(0.09)	$	(0.66)
Earnings (loss) per share attributable to Intel—diluted	$	(0.09)	$	(0.66)

Potentially dilutive shares of common stock from employee equity incentive plans are determined by applying the treasury stock method to the assumed exercise of outstanding stock options, the assumed vesting of outstanding RSUs, and the assumed issuance of common stock under the stock purchase plan.

Due to our net losses in the three months ended March 30, 2024 and April 1, 2023, the assumed exercise of outstanding stock options, the assumed vesting of outstanding RSUs, and the assumed issuance of common stock under the stock purchase plan had an anti-dilutive effect on diluted loss per share for the period and were excluded from the computation of diluted loss per share.

Note 5 : Other Financial Statement Details

Accounts Receivable

We sell certain of our accounts receivable on a non-recourse basis to third-party financial institutions. We record these transactions as sales of receivables and present cash proceeds as cash provided by operating activities in the Consolidated Condensed Statements of Cash Flows. Accounts receivable sold under non-recourse factoring arrangements were $500 million during the first three months of 2024 ($500 million in the first three months of 2023). After the sale of our accounts receivable, we expect to collect payment from the customers and remit it to the third-party financial institution.

Inventories

(In Millions)	Mar 30, 2024		Dec 30, 2023
Raw materials	$	1,209	$	1,166
Work in process	6,560		6,203
Finished goods	3,725		3,758
Total inventories	$	11,494	$	11,127

Other Accrued Liabilities

Other accrued liabilities include deferred compensation of $2.9 billion as of March 30, 2024 ($2.9 billion as of December 30, 2023).

Interest and Other, Net

	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Interest income	$	323	$	334
Interest expense	(258)		(193)
Other, net	80		—
Total interest and other, net	$	145	$	141

Interest expense is net of $363 million of interest capitalized in the first three months of 2024 ($363 million in the first three months of 2023).

Financial Statements  Notes to Financial Statements 13

Note 6 : Restructuring and Other Charges

	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Employee severance and benefit arrangements	$	129	$	(39)
Litigation charges and other	—		77
Asset impairment charges	219		26
Total restructuring and other charges	$	348	$	64

Employee severance and benefit arrangements includes a charge of $129 million in the first quarter of 2024 relating to actions taken to streamline operations and to reduce costs. We expect these actions to be substantially completed by the third quarter of 2024, but this is subject to change. Any changes to the estimates or timing will be reflected in our results of operations.

Asset impairment charges includes a goodwill impairment loss of $222 million in the first quarter of 2024 related to our new Intel Foundry reporting unit. Refer to "Note 2: Operating Segments" within Notes to Consolidated Condensed Financial Statements for further information on our business reorganization and goodwill impairment.

Note 7 : Income Taxes

	Three Months Ended
(In Millions)	Mar 30, 2024			Apr 1, 2023
Income (loss) before taxes	$	(719)		$	(1,158)
Provision for (benefit from) taxes	$	(282)		$	1,610
Effective tax rate	39.2		%	(139.0)		%

Our provision for, or benefit from, income taxes for an interim period has historically been determined using an estimated annual effective tax rate, adjusted for discrete items, if any. Under certain circumstances where we are unable to make a reliable estimate of the annual effective tax rate, we use the actual effective tax rate for the year-to-date period. During the first quarter of 2024, we used the actual effective tax rate approach due to the variability of the rate as a result of fluctuations in forecasted income and the effects of being taxed in multiple tax jurisdictions.

Note 8 : Investments

Short-term Investments

Short-term investments include marketable debt investments in corporate debt, government debt, and financial institution instruments, and are recorded within cash and cash equivalents and short-term investments on the Consolidated Condensed Balance Sheets. Government debt includes instruments such as non-US government bills and bonds and US agency securities. Financial institution instruments include instruments issued or managed by financial institutions in various forms, such as commercial paper, fixed- and floating-rate bonds, money market fund deposits, and time deposits. As of March 30, 2024, and December 30, 2023, substantially all time deposits were issued by institutions outside the US.

For certain of our marketable debt investments, we economically hedge market risks at inception with a related derivative instrument or the marketable debt investment itself is used to economically hedge currency exchange rate risk from remeasurement. These hedged investments are reported at fair value with gains or losses from the investments and the related derivative instruments recorded in interest and other, net. The fair value of our hedged investments was $13.8 billion as of March 30, 2024 ($17.1 billion as of December 30, 2023). For hedged investments still held at the reporting date, we recorded net losses of $307 million in the first three months of 2024 ($90 million of net gains in the first three months of 2023). We recorded net gains on the related derivatives of $345 million in the first three months of 2024 ($102 million of net losses in the first three months of 2023).

Our remaining unhedged marketable debt investments are reported at fair value, with unrealized gains or losses, net of tax, recorded in accumulated other comprehensive income (loss) and realized gains or losses recorded in interest and other, net. The adjusted cost of our unhedged investments was $4.0 billion as of March 30, 2024 ($4.7 billion as of December 30, 2023), which approximated the fair value for these periods.

Financial Statements  Notes to Financial Statements 14

The fair value of marketable debt investments, by contractual maturity, as of March 30, 2024, was as follows:

(In Millions)	Fair Value
Due in 1 year or less	$	5,579
Due in 1–2 years	2,457
Due in 2–5 years	6,915
Due after 5 years	433
Instruments not due at a single maturity date1	2,460
Total	$	17,844

1 Instruments not due at a single maturity date is comprised of money market fund deposits, which are classified as either short-term investments or cash and cash equivalents.

Equity Investments

(In Millions)	Mar 30, 2024		Dec 30, 2023
Marketable equity securities1	$	1,471	$	1,194
Non-marketable equity securities	4,664		4,630
Equity method investments	4		5
Total	$	6,139	$	5,829

1    Approximately 90% of our marketable equity securities are subject to trading-volume or market-based restrictions, which limit the number of shares we may sell in a specified period of time, impacting our ability to liquidate these investments. Certain of the trading volume restrictions generally apply for as long as we own more than 1% of the outstanding shares. Market-based restrictions result from the rules of the respective exchange.

The components of gains (losses) on equity investments, net for each period were as follows:

	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Ongoing mark-to-market adjustments on marketable equity securities	$	(91)	$	188
Observable price adjustments on non-marketable equity securities	24		10
Impairment charges	(69)		(36)
Sale of equity investments and other1	341		7
Total gains (losses) on equity investments, net	$	205	$	169

1 Sale of equity investments and other includes initial fair value adjustments recorded upon a security becoming marketable, realized gains (losses) on sales of non-marketable equity investments and equity method investments, and our share of equity method investee gains (losses) and distributions.

Note 9 : Divestitures

NAND Memory Business

The NAND memory business included our NAND memory technology and manufacturing business (the NAND OpCo Business), which we deconsolidated upon closing the first phase of our sale agreement with SK hynix Inc (SK hynix) on December 29, 2021. We have a receivable within other current assets for the remaining proceeds of $2.0 billion, which remains outstanding as of March 30, 2024 and will be received upon the second closing of the transaction, expected to be in March 2025.

The wafer manufacturing and sale agreement includes incentives and penalties that are contingent on the cost of operation and output of the NAND OpCo Business. These incentives and penalties present a maximum exposure of up to $500 million annually, and $1.5 billion in the aggregate. We are currently in negotiations with SK hynix to update the operating plan of the NAND OpCo Business, which may impact the metrics associated with the incentives and penalties and our expectations of the performance of the NAND OpCo Business against those metrics.

We were reimbursed for costs that we incurred on behalf of the NAND OpCo Business for corporate function services, which include human resources, information technology, finance, supply chain, and other compliance requirements. We recorded a receivable related to these reimbursable costs due from the NAND OpCo Business, a deconsolidated entity, of $150 million within other current assets as of March 30, 2024 ($145 million recorded as of December 30, 2023).

Financial Statements  Notes to Financial Statements 15

Note 10 : Borrowings

In the first quarter of 2024, we issued a total of $2.6 billion aggregate principal amount of senior notes. We also expanded both our 5-year $5.0 billion revolving credit facility agreement and our 364-day $5.0 billion credit facility agreement, to $7.0 billion and $8.0 billion, respectively, and the maturity dates were extended by one year to February 2029 and January 2025, respectively. The revolving credit facilities had no borrowings outstanding as of March 30, 2024.

We have an ongoing authorization from our Board of Directors to borrow up to $10.0 billion under our commercial paper program. We had $793 million of commercial paper outstanding as of March 30, 2024 (no commercial paper outstanding as of December 30, 2023).

Our senior fixed rate notes pay interest semiannually. We may redeem the fixed rate notes prior to their maturity at our option at specified redemption prices and subject to certain restrictions. The obligations under our senior fixed rate notes rank equally in the right of payment with all of our other existing and future senior unsecured indebtedness and effectively rank junior to all liabilities of our subsidiaries.

Note 11 : Fair Value

Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis

	Mar 30, 2024								Dec 30, 2023
	Fair Value Measured and Recorded at Reporting Date Using								Fair Value Measured and Recorded at Reporting Date Using
(In Millions)	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Assets
Cash equivalents:
Corporate debt	$	—	$	231	$	—	$	231	$	—	$	769	$	—	$	769
Financial institution instruments¹	2,438		787		—		3,225		2,241		835		—		3,076
Reverse repurchase agreements	—		2,370		—		2,370		—		2,554		—		2,554
Short-term investments:
Corporate debt	—		6,298		—		6,298		—		6,951		—		6,951
Financial institution instruments¹	22		3,777		—		3,799		33		4,215		—		4,248
Government debt²	—		4,291		—		4,291		—		6,756		—		6,756
Other current assets:
Derivative assets	34		739		—		773		366		809		—		1,175
Marketable equity securities	1,471		—		—		1,471		1,194		—		—		1,194
Other long-term assets:
Derivative assets	—		6		—		6		—		21		—		21
Total assets measured and recorded at fair value	$	3,965	$	18,499	$	—	$	22,464	$	3,834	$	22,910	$	—	$	26,744
Liabilities
Other accrued liabilities:
Derivative liabilities	$	—	$	375	$	118	$	493	$	—	$	541	$	99	$	640
Other long-term liabilities:
Derivative liabilities	—		611		—		611		—		479		—		479
Total liabilities measured and recorded at fair value	$	—	$	986	$	118	$	1,104	$	—	$	1,020	$	99	$	1,119

1Level 1 investments consist of money market funds. Level 2 investments consist primarily of certificates of deposit, time deposits, commercial paper, notes and bonds issued by financial institutions.

2Level 2 investments consist primarily of non-US government debt.

Assets Measured and Recorded at Fair Value on a Non-Recurring Basis

Our non-marketable equity securities, equity method investments, and certain non-financial assets—such as intangible assets, goodwill, and property, plant, and equipment—are recorded at fair value only if an impairment or observable price adjustment is recognized in the current period. If an observable price adjustment or impairment is recognized on our non-marketable equity securities during the period, we classify these assets as Level 3.

Financial Statements  Notes to Financial Statements 16

Financial Instruments Not Recorded at Fair Value on a Recurring Basis

Financial instruments not recorded at fair value on a recurring basis include non-marketable equity securities and equity method investments that have not been remeasured or impaired in the current period, grants receivable, certain other receivables, and issued debt. We classify the fair value of grants receivable as Level 2. The estimated fair value of these financial instruments approximates their carrying value. The aggregate carrying value of grants receivable as of March 30, 2024 was $666 million (the aggregate carrying value as of December 30, 2023 was $559 million).

We classify the fair value of issued debt (excluding any commercial paper) as Level 2. The fair value of our issued debt was $48.7 billion as of March 30, 2024 ($47.6 billion as of December 30, 2023).

Note 12 : Derivative Financial Instruments

Volume of Derivative Activity

Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows: 

(In Millions)	Mar 30, 2024		Dec 30, 2023
Foreign currency contracts	$	27,942	$	30,064
Interest rate contracts	18,611		18,363
Other	2,507		2,103
Total	$	49,060	$	50,530

The total notional amount of outstanding pay-variable, receive-fixed interest rate swaps was $12.0 billion as of March 30, 2024 and December 30, 2023.

Fair Value of Derivative Instruments in the Consolidated Condensed Balance Sheets

	Mar 30, 2024				Dec 30, 2023
(In Millions)	Assets1		Liabilities2		Assets1		Liabilities2
Derivatives designated as hedging instruments:
Foreign currency contracts3	$	69	$	307	$	255	$	142
Interest rate contracts	—		723		—		578
Total derivatives designated as hedging instruments	$	69	$	1,030	$	255	$	720
Derivatives not designated as hedging instruments:
Foreign currency contracts3	$	391	$	65	$	314	$	363
Interest rate contracts	285		9		261		36
Equity contracts	34		—		366		—
Total derivatives not designated as hedging instruments	$	710	$	74	$	941	$	399
Total derivatives	$	779	$	1,104	$	1,196	$	1,119

1Derivative assets are recorded as other assets, current and long-term.

2Derivative liabilities are recorded as other liabilities, current and long-term.

3A substantial majority of these instruments mature within 12 months.

Financial Statements  Notes to Financial Statements 17

Amounts Offset in the Consolidated Condensed Balance Sheets

Agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows:

	Mar 30, 2024
							Gross Amounts Not Offset in the Balance Sheet
(In Millions)	Gross Amounts Recognized		Gross Amounts Offset in the Balance Sheet		Net Amounts Presented in the Balance Sheet		Financial Instruments		Cash and Non-Cash Collateral Received or Pledged		Net Amount
Assets:
Derivative assets subject to master netting arrangements	$	632	$	—	$	632	$	(350)	$	(282)	$	—
Reverse repurchase agreements	2,370		—		2,370		—		(2,370)		—
Total assets	$	3,002	$	—	$	3,002	$	(350)	$	(2,652)	$	—
Liabilities:
Derivative liabilities subject to master netting arrangements	$	1,097	$	—	$	1,097	$	(350)	$	(620)	$	127
Total liabilities	$	1,097	$	—	$	1,097	$	(350)	$	(620)	$	127

	Dec 30, 2023
							Gross Amounts Not Offset in the Balance Sheet
(In Millions)	Gross Amounts Recognized		Gross Amounts Offset in the Balance Sheet		Net Amounts Presented in the Balance Sheet		Financial Instruments		Cash and Non-Cash Collateral Received or Pledged		Net Amount
Assets:
Derivative assets subject to master netting arrangements	$	1,047	$	—	$	1,047	$	(617)	$	(430)	$	—
Reverse repurchase agreements	2,554		—		2,554		—		(2,554)		—
Total assets	$	3,601	$	—	$	3,601	$	(617)	$	(2,984)	$	—
Liabilities:
Derivative liabilities subject to master netting arrangements	$	1,111	$	—	$	1,111	$	(617)	$	(399)	$	95
Total liabilities	$	1,111	$	—	$	1,111	$	(617)	$	(399)	$	95

We obtain and secure available collateral from counterparties against obligations, including securities lending transactions and reverse repurchase agreements, when we deem it appropriate.

Derivatives in Cash Flow Hedging Relationships

The before-tax net gains or losses attributed to cash flow hedges recognized in other comprehensive income (loss) were $431 million net loss in the first three months of 2024 ($53 million net gains in the first three months of 2023). Substantially all of our cash flow hedges were foreign currency contracts for all periods presented.

During the first three months of 2024 and 2023, the amounts excluded from effectiveness testing were insignificant.

Financial Statements  Notes to Financial Statements 18

Derivatives in Fair Value Hedging Relationships    

The effects of derivative instruments designated as fair value hedges, recognized in interest and other, net for each period were as follows:

	Gains (Losses) on Derivatives Recognized in Consolidated Condensed Statements of Income
	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Interest rate contracts	$	(144)	$	192
Hedged items	144		(192)
Total	$	—	$	—

The amounts recorded on the Consolidated Condensed Balance Sheets related to cumulative basis adjustments for fair value hedges for each period were as follows:

Line Item in the Consolidated Condensed Balance Sheets in Which the Hedged Item is Included	Carrying Amount of the Hedged Item Assets/(Liabilities)				Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount Assets/(Liabilities)
(In Millions)	Mar 30, 2024		Dec 30, 2023		Mar 30, 2024		Dec 30, 2023
Long-term debt	$	(11,275)	$	(11,419)	$	722	$	578

Derivatives Not Designated as Hedging Instruments

The effects of derivative instruments not designated as hedging instruments on the Consolidated Condensed Statements of Income for each period were as follows:

		Three Months Ended
(In Millions)	Location of Gains (Losses) Recognized in Income on Derivatives	Mar 30, 2024		Apr 1, 2023
Foreign currency contracts	Interest and other, net	$	346	$	1
Interest rate contracts	Interest and other, net	117		(34)
Other	Various	137		115
Total		$	600	$	82

Note 13 : Contingencies

Legal Proceedings

We are regularly party to various ongoing claims, litigation, and other proceedings, including those noted in this section. We have accrued a charge of $1.0 billion related to litigation involving VLSI and a charge of $401 million related to an EC-imposed fine, both as described below. Excluding the VLSI claims, management at present believes that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations, cash flows, or overall trends; however, legal proceedings and related government investigations are subject to inherent uncertainties, and unfavorable rulings, excessive verdicts, or other events could occur. Unfavorable resolutions could include substantial monetary damages, fines, or penalties. Certain of these outstanding matters include speculative, substantial, or indeterminate monetary awards. In addition, in matters for which injunctive relief or other conduct remedies are sought, unfavorable resolutions could include an injunction or other order prohibiting us from selling one or more products at all or in particular ways, precluding particular business practices, or requiring other remedies. An unfavorable outcome may result in a material adverse impact on our business, results of operations, financial position, and overall trends. We might also conclude that settling one or more such matters is in the best interests of our stockholders, employees, and customers, and any such settlement could include substantial payments. Unless specifically described below, we have not concluded that settlement of any of the legal proceedings noted in this section is appropriate at this time.

Financial Statements  Notes to Financial Statements 19

European Commission Competition Matter

In 2009, the EC found that we had used unfair business practices to persuade customers to buy microprocessors in violation of Article 82 of the EC Treaty (later renumbered Article 102) and Article 54 of the European Economic Area Agreement. In general, the EC found that we violated Article 82 by offering alleged “conditional rebates and payments” that required customers to purchase all or most of their x86 microprocessors from us and by making alleged “payments to prevent sales of specific rival products.” The EC ordered us to end the alleged infringement referred to in its decision and imposed a €1.1 billion fine, which we paid in the third quarter of 2009.

We appealed the EC decision to the European Court of Justice in 2014, after the General Court (then called the Court of First Instance) rejected our appeal of the EC decision in its entirety. In September 2017, the Court of Justice sent the case back to the General Court to examine whether the rebates at issue were capable of restricting competition. In January 2022, the General Court annulled the EC’s 2009 findings against us regarding rebates, as well as the €1.1 billion fine imposed on Intel, which was returned to us in February 2022. The General Court’s January 2022 decision did not annul the EC’s 2009 finding that we made payments to prevent sales of specific rival products.

In April 2022 the EC appealed the General Court’s decision to the Court of Justice. In addition, in September 2023 the EC imposed a €376 million ($401 million) fine against us based on its finding that we made payments to prevent sales of specific rival products. We have appealed the EC’s decision. We have accrued a charge for the fine and are unable to make a reasonable estimate of the potential loss or range of losses in excess of this amount given the procedural posture and the nature of these proceedings.

In a related matter, in April 2022 we filed applications with the General Court seeking an order requiring the EC to pay us approximately €593 million in default interest on the original €1.1 billion fine that was held by the EC for 12 years, which applications have been stayed pending the EC’s appeal of the General Court’s January 2022 decision.

Litigation Related to Security Vulnerabilities

In June 2017, a Google research team notified Intel and other companies that it had identified security vulnerabilities, the first variants of which are now commonly referred to as “Spectre” and “Meltdown,” that affect many types of microprocessors, including our products. As is standard when findings like these are presented, we worked together with other companies in the industry to verify the research and develop and validate software and firmware updates for impacted technologies. In January 2018, information on the security vulnerabilities was publicly reported, before software and firmware updates to address the vulnerabilities were made widely available.

As of April 24, 2024, consumer class action lawsuits against us were pending in the US and Canada. The plaintiffs, who purport to represent various classes of purchasers of our products, generally claim to have been harmed by our actions and/or omissions in connection with Spectre, Meltdown, and other variants of this class of security vulnerabilities that have been identified since 2018, and assert a variety of common law and statutory claims seeking monetary damages and equitable relief. In the US, class action suits filed in various jurisdictions between 2018 and 2021 were consolidated for all pretrial proceedings in the US District Court for the District of Oregon, which entered final judgment in favor of Intel in July 2022 based on plaintiffs’ failure to plead a viable claim. The Ninth Circuit Court of Appeals affirmed the district court’s judgment in November 2023, ending the litigation. In November 2023, new plaintiffs filed a consumer class action complaint in the US District Court for the Northern District of California with respect to a further vulnerability variant disclosed in August 2023 and commonly referred to as “Downfall.” We moved to dismiss that complaint in January 2024. In Canada, an initial status conference has not yet been scheduled in one case relating to Spectre and Meltdown pending in the Superior Court of Justice of Ontario, and a stay of a second case pending in the Superior Court of Justice of Quebec is in effect. In a class action relating to Spectre and Meltdown previously pending in Argentina, plaintiffs’ appeal of a May 2023 order dismissing their complaint for lack of standing was denied in February 2024, ending the lawsuit. Additional lawsuits and claims may be asserted seeking monetary damages or other related relief. Given the procedural posture and the nature of these cases, including that the pending proceedings are in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class or classes being certified or the ultimate size of any class or classes if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from these matters.

Litigation Related to 7nm Product Delay Announcement

Multiple securities class action lawsuits were filed in the US District Court for the Northern District of California against us and certain officers following our July 2020 announcement of 7nm product delays. The court consolidated the lawsuits and appointed lead plaintiffs in October 2020, and in January 2021 plaintiffs filed a consolidated complaint. Plaintiffs purport to represent all persons who purchased or otherwise acquired our common stock from October 25, 2019 through October 23, 2020, and they generally allege that defendants violated the federal securities laws by making false or misleading statements about the timeline for 7nm products. In March 2023, the district court granted the defendants’ motion to dismiss the consolidated complaint, and in April 2023 entered judgment. Plaintiffs appealed, and on April 19, 2024 the Ninth Circuit affirmed the judgment; the Ninth Circuit’s ruling is subject to appeal. Given the procedural posture and the nature of the case, including that it is in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class being certified or the ultimate size of any class if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from the matter. In July 2021, we introduced a new process node naming structure, and the 7nm process is now called Intel 4.

Financial Statements  Notes to Financial Statements 20

Litigation Related to Patent and IP Claims

We have had IP infringement lawsuits filed against us, including but not limited to those discussed below. Most involve claims that certain of our products, services, and technologies infringe others' IP rights. Adverse results in these lawsuits may include awards of substantial fines and penalties, costly royalty or licensing agreements, or orders preventing us from offering certain features, functionalities, products, or services. As a result, we may have to change our business practices, and develop non-infringing products or technologies, which could result in a loss of revenue for us and otherwise harm our business. In addition, certain agreements with our customers require us to indemnify them against certain IP infringement claims, which can increase our costs as a result of defending such claims, and may require that we pay significant damages, accept product returns, or supply our customers with non-infringing products if there were an adverse ruling in any such claims. In addition, our customers and partners may discontinue the use of our products, services, and technologies, as a result of injunctions or otherwise, which could result in loss of revenue and adversely affect our business.

VLSI Technology LLC v. Intel

In October 2017, VLSI Technology LLC (VLSI) filed a complaint against us in the US District Court for the Northern District of California alleging that various Intel FPGA and processor products infringe eight patents VLSI acquired from NXP Semiconductors, N.V. (NXP). Intel prevailed on all eight patents and the court entered final judgment in April 2024. Further appeals are possible. In April 2019, VLSI filed three infringement suits against us in the US District Court for the Western District of Texas accusing various of our processors of infringement of eight additional patents it had acquired from NXP:

▪The first Texas case went to trial in February 2021, and the jury awarded VLSI $1.5 billion for literal infringement of one patent and $675 million for infringement of another patent under the doctrine of equivalents. In April 2022, the court entered final judgment, awarding VLSI $2.1 billion in damages and approximately $162.3 million in pre-judgment and post-judgment interest. We appealed the judgment to the Federal Circuit Court of Appeals, including the court’s rejection of Intel’s claim to have a license from Fortress Investment Group’s acquisition of Finjan. The Federal Circuit Court heard oral argument in October 2023. In December 2023, the Federal Circuit reversed the finding of infringement as to the patent for which VLSI was awarded $675 million. The Federal Circuit affirmed the finding of infringement as to the patent for which VLSI had been awarded $1.5 billion, but vacated the damages award and sent the case back to the trial court for further damages proceedings on that patent. The Federal Circuit also ruled that Intel can advance the defense that it is licensed to VLSI’s patents. In December 2021 and January 2022 the Patent Trial and Appeal Board (PTAB) instituted Inter Partes Reviews (IPR) on the claims found to have been infringed in the first Texas case, and in May and June 2023 found all of those claims unpatentable; VLSI has appealed the PTAB’s decision. In March 2024, Intel filed a motion to stay the case pending appeals of the IPRs. In April 2024, Intel moved to add the defense that it is licensed to VLSI’s patents.

▪The second Texas case went to trial in April 2021, and the jury found that we do not infringe the asserted patents. VLSI had sought approximately $3.0 billion for alleged infringement, plus enhanced damages for willful infringement. The court has not yet entered final judgment.

▪The third Texas case went to trial in November 2022, with VLSI asserting one remaining patent. The jury found the patent valid and infringed, and awarded VLSI approximately $949 million in damages, plus interest and a running royalty. The court has not yet entered final judgment. In February 2023, we filed motions for a new trial and for judgment as a matter of law notwithstanding the verdict on various grounds. Further appeals are possible. In April 2024, Intel moved to add the defense that it is licensed to VLSI’s patents.

In May 2019, VLSI filed a case in Shenzhen Intermediate People’s Court against Intel, Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. VLSI asserted one patent against certain Intel Core processors. Defendants filed an invalidation petition in October 2019 with the China National Intellectual Property Administration (CNIPA) which held a hearing in September 2021. The Shenzhen court held trial proceedings in July 2021, and September 2023. VLSI sought an injunction as well as RMB 1.3 million in costs and expenses, but no damages. In September 2023, the CNIPA invalidated every claim of the asserted patent. In November 2023, the trial court dismissed VLSI’s case.

In May 2019, VLSI filed a case in Shanghai Intellectual Property Court against Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. asserting one patent against certain Intel core processors. The court held a trial hearing in December 2020, where VLSI requested expenses (RMB 300 thousand) and an injunction. In December 2022, we filed a petition to invalidate the patent at issue. The court held a second trial hearing in May 2022, and in October 2023, issued a decision finding no infringement and dismissing all claims. In November 2023, VLSI appealed the finding of non-infringement.

As of March 30, 2024, we have accrued a charge of approximately $1.0 billion related to the VLSI litigation. While we dispute VLSI’s claims and intend to vigorously defend against them, we are unable to make a reasonable estimate of losses in excess of recorded amounts given recent developments and future proceedings.

Financial Statements  Notes to Financial Statements 21

R2 Semiconductor Patent Litigation

In November 2022, R2 Semiconductor, Inc. (R2) filed a lawsuit in the High Court of Justice in the UK against Intel Corporation (UK) Limited and Intel Corporation, and a lawsuit in the Dusseldorf Regional Court in Germany against Intel Deutschland GmbH and certain Intel customers. R2 asserts one European patent is infringed by Intel’s Ice Lake, Tiger Lake, Alder Lake and Ice Lake Server (Xeon) processors (the accused products), and customer servers and laptops that contain those processors. R2 seeks an injunction in both actions prohibiting the sale and requiring the recall of the alleged infringing products. Intel is indemnifying its customers in the German lawsuit.

Intel disputes R2’s claims and intends to defend the lawsuits vigorously. In December 2022, Intel responded in the UK action that the asserted patent is not infringed and that the patent is invalid. In April 2023, defendants filed statements of defense in the German action that the asserted patent is not infringed and that an injunction would be a disproportionate remedy. In May 2023, defendants also filed a nullity action in the German Federal Patent Court on the ground that the asserted patent is invalid.

In December 2023, the German Federal Patent Court issued a preliminary opinion finding R2’s patent valid. The German Federal Patent Court’s final decision on invalidity is expected in October 2024. In December 2023, the court in Dusseldorf held a trial on the issue of infringement. In February 2024, the court found Intel’s processors infringe and issued an injunction and recall order against Intel and its customers. R2 has not yet sought to enforce the order. Intel has appealed the decision. In April 2024, Intel also filed a complaint with the Constitutional Court seeking a stay and a reversal of the finding of infringement and filed additional evidence with the appeals court to demonstrate that it does not infringe R2’s patent.

In March 2024, Intel filed an action in Milan, Italy seeking an order that it does not infringe R2’s patent.

In April 2024, R2 filed an action against Intel and its customers Dell, HP, and HPE for patent infringement in Paris, France. Intel and its customers have filed a nullity action against the patent in France.

Trial in the UK matter is scheduled for April 2024.

We are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from these lawsuits and the injunction and order of the Dusseldorf Regional Court due to the procedural posture and the nature of these cases, including that there are significant factual and legal issues to be resolved and that uncertainty exists as to, among other things: (i) whether and, if so, at what point in time the order in Germany may take effect, including as a result of a potential stay; (ii) whether and, if so, at what point we may be successful in appealing the decisions in Germany as to infringement and validity, (iii) the extent to which we and our customers are able to mitigate the impact of the injunction of the Dusseldorf Regional Court, (iv) the costs of recalling products if the recall order of the Dusseldorf Regional Court is enforced, (v) the extent to which R2 may be awarded damages, and (vi) the extent to which we may agree to compensate our customers for losses in connection with the injunction and recall and any potential damage award.

Financial Statements  Notes to Financial Statements 22

Key Terms

We use terms throughout our document that are specific to Intel or that are abbreviations that may not be commonly known or used. Below is a list of these terms used in our document.

Term	Definition
5G	The fifth-generation mobile network, which brings dramatic improvements in network speeds and latency, and which we view as a transformative technology and opportunity for many industries
ADAS	Advanced driver-assistance systems
AI	Artificial intelligence
ASIC	Application-specific integrated circuit
ASP	Average selling price
Back end services	Includes assembly, test and packaging services
CCG	Client Computing Group operating segment
CODM	Chief operating decision maker
DCAI	Data Center and Artificial Intelligence operating segment
EC	European Commission
EPS	Earnings per share
Form 10-K	Annual Report on Form 10-K for the year ended December 30, 2023
Form 10-Q	Quarterly Report on Form 10-Q for the quarter ended March 30, 2024
FPGA	Field-programmable gate array
HPC	High performance computing
IDM 2.0	Evolution of our IDM model that combines our internal factory network, strategic use of foundry capacity and our IFS business to position us to drive technology and product leadership
IP	Intellectual property
IPO	Initial public offering
MD&A	Management's Discussion and Analysis
MG&A	Marketing, general, and administrative
NAND	NAND flash memory
NEX	Networking and Edge operating segment
nm	Nanometer
R&D	Research and development
RSU	Restricted stock unit
SEC	US Securities and Exchange Commission
Smart Capital	Our Smart Capital approach accelerates progress on our IDM 2.0 strategy. This approach is designed to enable us to adjust quickly to opportunities in the market, while managing our margin structure and capital spending. The elements of Smart Capital include capacity investments, government incentives, customer commitments, continued use of external foundries.
SoC	A system on a chip, which integrates most of the components of a computer or other electronic system into a single silicon chip. We offer a range of SoC products in CCG, DCAI, and NEX. Our DCAI and NEX businesses offer SoCs across many market segments for a variety of applications, including products targeted for 5G base stations and network infrastructure
US	United States
US GAAP	US Generally Accepted Accounting Principles
VIE	Variable interest entity
VLSI	VLSI Technology LLC

Financial Statements  Notes to Financial Statements 23

Management's Discussion and Analysis

This report should be read in conjunction with our Form 10-K where we include additional information on our business, operating segments, risk factors, critical accounting estimates, policies, and the methods and assumptions used in our estimates, among other important information.

"Note 2: Operating Segments” within Notes to Consolidated Condensed Financial Statements of this Form 10-Q provides additional information about our operating segments including the nature of segment revenues and expenses and reconciles our segment revenues presented below to our total consolidated net revenues, and our segment operating income (loss) presented below to our total consolidated operating income (loss), for each of the periods presented.

For additional key highlights of our results of operations, see "A Quarter in Review."

Intel Products

Intel Products consists substantially of design and development of CPUs and related solutions for third party customers. Intel Products is comprised of three operating segments: CCG, DCAI, and NEX.

Financial Performance

Intel Products Operating Segments Revenue $B Intel Products Segments Operating Income $B

Operating Segments Revenue and Segments Operating Income Summary

Q1 2024 vs. Q1 2023

Total Intel Products revenue was $11.9 billion in Q1 2024 and $10.2 billion in Q1 2023. Revenue increased primarily due to our CCG operating segment. Total Intel Products operating income increased to $3.3 billion, or 28% operating margin for Q1 2024 from $1.1 billion or 11% operating margin in Q1 2023. This Q1 2024 increase is primarily due to higher CCG revenue, lower period charges across each of the Intel Products' operating segments due to the sell-through of previously reserved inventory and lower reserves taken, and lower CCG operating expenses and sample costs, partially offset by higher Q1 2024 unit costs in DCAI and CCG.

MD&A 24

Client Computing Group

We are committed to advancing PC experiences by delivering an annual cadence of leadership products and deepening our relationships with industry partners to co-engineer and deliver leading platform innovation. We engage in an intentional effort to bring together the operating system, system architecture, hardware, and software application integration to enable industry-leading PC experiences. We embrace these opportunities by focusing our roadmap, delivering innovative PC capabilities, and designing advanced PC experiences. By doing this, we believe we help continue to fuel innovation across the industry, providing a solid source of IP, scale, and cash flow for Intel.

Financial Performance

CCG Operating Segment Revenue $B CCG Segment Operating Income $B

■ | ■ Notebook   ■ | ■ Desktop   ■ | ■ Other

Operating Segment Revenue Summary

Q1 2024 vs. Q1 2023

▪Notebook revenue was $4.7 billion, up $1.3 billion from Q1 2023 and desktop revenue was $2.5 billion, up $582 million from Q1 2023. Notebook volume increased 39% in Q1 2024 and desktop volume increased 29% in Q1 2024 as customer inventory levels normalized compared to higher levels in Q1 2023. Notebook and desktop ASPs were roughly flat with Q1 2023.

▪Other revenue was $391 million, down $90 million from Q1 2023 primarily driven by the exit of legacy businesses.

Segment Operating Income Summary

Operating income increased 124% from Q1 2023, with an operating margin of 35%.

(In Millions)
$	2,645	Q1 2024 Operating Income
987		Higher product profit primarily from higher notebook and desktop revenue
285		Lower period charges primarily driven by the sell-through of previously reserved inventory
163		Lower operating expenses driven by various cost-cutting measures
154		Lower period charges primarily driven by lower product sample costs
(124)		Higher unit costs primarily from increased mix of Intel 4 and Intel 7 products
$	1,180	Q1 2023 Operating Income

MD&A 25

Data Center and AI

DCAI delivers cutting-edge workload-optimized solutions to cloud service providers and enterprises, along with silicon devices for communications service providers, network and edge, and HPC customers. Our unique capabilities enable us to help solve our customers' most complex challenges with the depth and breadth of our hardware and software portfolio, advanced packaging, and at-scale manufacturing made possible through a resilient, global supply chain. Our global customers and partners encompass cloud hyperscalers, multinational corporations, small-and medium-sized enterprises, independent software vendors, systems integrators, communications service providers, and governments.

Financial Performance

DCAI Operating Segment Revenue $B DCAI Segment Operating Income $B

Operating Segment Revenue Summary

Q1 2024 vs. Q1 2023

Revenue was $3.0 billion, up $135 million from Q1 2023, driven by an increase in server revenue. Server ASPs increased 25% primarily due to a lower mix of hyperscale customer-related revenue and a higher mix of high core count products. Server volume decreased 13% in Q1 2024, due to lower demand in a competitive environment and a higher mix of high core count products.

Segment Operating Income Summary

Operating income increased $460 million from Q1 2023, with an operating margin of 16%.

(In Millions)
$	482	Q1 2024 Operating Income
429		Higher product profit primarily from higher server revenue
310		Lower period charges primarily driven by the sell-through of previously reserved inventory and lower reserves taken
(279)		Higher server unit cost primarily from increased mix of Intel 7 products
$	22	Q1 2023 Operating Income

MD&A 26

Network & Edge

NEX lifts the world's networks and edge compute systems from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. We work with partners and customers to deliver and deploy intelligent edge platforms that allow software developers to achieve agility and to drive automation using AI for efficient operations while securing the integrity of their data at the edge. We have a broad portfolio of hardware and software platforms, tools, and ecosystem partnerships for the rapid digital transformation happening from the cloud to the edge. We are leveraging our core strengths in process, software, and manufacturing at scale to grow traditional markets and to accelerate entry into emerging ones.

Financial Performance

NEX Operating Segment Revenue $B NEX Segment Operating Income (Loss) $B

Operating Segment Revenue Summary

Q1 2024 vs. Q1 2023

Revenue was $1.4 billion, down $125 million from Q1 2023 primarily due to 5G customers tempering purchases to reduce existing inventories, partially offset by higher Edge and Network revenue.

Segment Operating Income (Loss) Summary

Operating margin increased $253 million from Q1 2023, with an operating margin of 13%.

(In Millions)
$	184	Q1 2024 Operating Income (Loss)
185		Lower period charges driven by the sell-through of previously reserved inventory and lower reserves taken
68		Other
$	(69)	Q1 2023 Operating Income (Loss)

MD&A 27

Intel Foundry

Intel Foundry, comprising our Foundry Technology Development, Foundry Manufacturing and Supply Chain, and Foundry Services organizations, is on a mission to deliver the best systems foundry capabilities to our customers and reshape the world’s semiconductor industry. As the stewards of Moore’s law, we continually innovate and advance world-class silicon process and advanced packaging technologies for customers. Our systems foundry offerings are strengthened by a robust design ecosystem with key industry partners, our systems of chips capabilities, and our secure, resilient and more sustainable supply chain. Our systems foundry is built on the foundation of our silicon process and advanced packaging technology offerings and enables co-optimized solutions for our customers in the AI era. We are strengthening the resilience of the global semiconductor supply chain for leading-edge and mature node semiconductor products by investing in geographically balanced and more sustainable manufacturing capacity. As a systems foundry for the AI era, Intel Foundry brings together these critical components to help our global customers drive the next phase of technology innovation.

Financial Performance

Intel Foundry Operating Segment Revenue $B Intel Foundry Segment Operating Loss $B

Operating Segment Revenue Summary

Q1 2024 vs. Q1 2023

Revenue was $4.4 billion, down $462 million from Q1 2023. Intersegment revenue was $4.3 billion, down $371 million from Q1 2023, driven by lower back end services and product sample revenues. External revenue was $27 million, down $91 million from Q1 2023, driven by lower equipment sales and traditional packaging services.

Segment Operating Loss Summary

We had an operating loss of $2.5 billion, compared to an operating loss of $2.4 billion in Q1 2023.

(In Millions)
$	(2,474)	Q1 2024 Operating Loss
(367)		Lower product and services profit primarily driven by lower revenue
300		Lower period charges related to excess capacity charges
209		Lower period charges primarily driven by lower intersegment inventory reserves taken
(256)		Higher period charges primarily related to factory start-up costs and process development costs
$	(2,360)	Q1 2023 Operating Loss

MD&A 28

All Other

Our "all other" category includes results of operations from our Altera and Mobileye businesses, from "other" non-reportable segments not otherwise presented, from start-up businesses that support our initiatives, and historical results of operations from divested businesses. Altera offers programmable semiconductors, primarily FPGAs, CPLDs, acceleration platforms, software, IP, and related products, for a broad range of applications across our embedded, communications, cloud, and enterprise market segments. Mobileye is a global leader in driving assistance and self-driving solutions, with a product portfolio designed to encompass the entire stack required for assisted and autonomous driving, including compute platforms, computer vision, and machine learning-based perception, mapping and localization, driving policy, and active sensors in development.

Financial Performance

All Other Operating Segments Revenue $B All Other Segments Operating Income (Loss) $B

Operating Segments Revenue and Segments Operating Income (Loss) Summary

Q1 2024 vs. Q1 2023

All other revenue was $775 million, down $665 million from Q1 2023. Altera revenue decreased $474 million from Q1 2023, as customers tempered purchases to reduce existing inventories across all product lines. Mobileye revenue decreased $219 million from Q1 2023, as customers tempered purchases to reduce existing inventories of EyeQ products. All other operating loss was $212 million in Q1 2024 compared to operating income of $347 million in Q1 2023 due primarily to lower Altera and Mobileye revenues.

MD&A 29

Consolidated Condensed Results of Operations

	Three Months Ended
	Q1 2024				Q1 2023
(In Millions, Except Per Share Amounts)	Amount		% of Net Revenue		Amount		% of Net Revenue
Net revenue	$	12,724	100.0	%	$	11,715	100.0	%
Cost of sales	7,507		59.0	%	7,707		65.8	%
Gross margin	5,217		41.0	%	4,008		34.2	%
Research and development	4,382		34.4	%	4,109		35.1	%
Marketing, general, and administrative	1,556		12.2	%	1,303		11.1	%
Restructuring and other charges	348		2.7	%	64		0.5	%
Operating income (loss)	(1,069)		(8.4)	%	(1,468)		(12.5)	%
Gains (losses) on equity investments, net	205		1.6	%	169		1.4	%
Interest and other, net	145		1.1	%	141		1.2	%
Income (loss) before taxes	(719)		(5.7)	%	(1,158)		(9.9)	%
Provision for (benefit from) taxes	(282)		(2.2)	%	1,610		13.7	%
Net income (loss)	(437)		(3.4)	%	(2,768)		(23.6)	%
Less: Net income (loss) attributable to non-controlling interests	(56)		(0.4)	%	(10)		(0.1)	%
Net income (loss) attributable to Intel	$	(381)	(3.0)	%	$	(2,758)	(23.5)	%
Earnings (loss) per share attributable to Intel—diluted	$	(0.09)			$	(0.66)

MD&A 30

Consolidated Revenue

Consolidated Revenue Walk $B1

Q1 2024 vs. Q1 2023

Our Q1 2024 revenue was $12.7 billion, up $1.0 billion or 9% from Q1 2023. CCG revenue increased 31% from Q1 2023 primarily due to higher notebook and desktop volumes as customer inventory levels normalized compared to higher levels in Q1 2023. Notebook and desktop ASPs were roughly flat with Q1 2023. DCAI revenue increased 5% from Q1 2023 due to higher server ASPs primarily due to a lower mix of hyperscale customer-related revenue and a higher mix of high core count products, partially offset by lower server volume due to lower demand in a competitive environment. NEX revenue decreased 8% primarily due to 5G customers tempering purchases to reduce existing inventories, partially offset by higher Edge and Network Xeon revenue. Altera revenue decreased 58% from Q1 2023 as customers tempered purchases to reduce existing inventories across all product lines and Mobileye revenue decreased 48% from Q1 2023 as customers tempered purchases to reduce existing inventories across EyeQ products. External Intel Foundry revenue decreased 77% from Q1 2023 due to lower multi-beam mask writer tool sales.

Incentives offered to certain customers to accelerate purchases and to strategically position our products with customers for market segment share purposes, particularly in CCG, contributed approximately $1.6 billion to our revenue during Q1 2024 compared to approximately $900 million during Q1 2023. The impacts of these Q1 2024 incentives were contemplated in our financial guidance for Q2 2024, as included in our Form 8-K dated April 25, 2024.

1 Excludes intersegment revenue

MD&A 31

Consolidated Gross Margin

We derived a substantial majority of our overall gross margin in Q1 2024 primarily from our Intel Products business sales through our CCG, DCAI, and NEX operating segments. Our overall gross margin dollars in Q1 2024 increased by $1.2 billion, or 30%, compared to Q1 2023.

Consolidated Gross Margin $B1

(Percentages in chart indicate gross margin as a percentage of total revenue)

(In Millions)
$	5,217	Q1 2024 Gross Margin
1,079		Higher product profit primarily from higher notebook and desktop revenue
553		Lower period charges driven by the sell-through of previously reserved inventory and lower reserves taken
407		Higher product profit primarily due to higher server revenue
300		Lower period charges related to excess capacity charges
138		Lower period charges primarily driven by a decrease in product sample costs
(540)		Lower product profit primarily from lower Altera and Mobileye revenue
(313)		Higher unit cost primarily from increased mix of Intel 7 and Intel 4 products
(213)		Higher period charges primarily related to factory start-up costs and process development costs
(202)		Other
$	4,008	Q1 2023 Gross Margin

1 Excludes intersegment activity

MD&A 32

Consolidated Operating Expenses

Total R&D and MG&A expenses for Q1 2024 were $5.9 billion, up 10% from Q1 2023. These expenses represent 46.7% of revenue for Q1 2024 and 46.2% of revenue for Q1 2023. In support of our strategy, described in our 2023 Form 10-K, we continue to make significant investments to accelerate our process technology roadmap. This requires continued investments in R&D and focused efforts to attract and retain talent. We continue to focus on cost efficiency initiatives that may offset some of the incremental costs that may be required periodically as we continue to improve our product execution and cost structure.

Research and Development $B Marketing, General, and Administrative $B

(Percentages in chart indicate operating expenses as a percentage of total revenue)

Research and Development

Q1 2024 vs. Q1 2023

R&D increased by $273 million, or 7%, driven by the following:
+	Higher share-based compensation and incentive-based cash compensation
-	The effects of various cost-cutting measures

Marketing, General, and Administrative

Q1 2024 vs. Q1 2023

MG&A increased by $253 million, or 19%, driven by the following:
+	Higher share-based compensation and incentive-based cash compensation
+	Increase in corporate spending, primarily from higher marketing expenses

Restructuring and Other Charges

(In Millions)	Q1 2024		Q1 2023
Employee severance and benefit arrangements	$	129	$	(39)
Litigation charges and other	—		77
Asset impairment charges	219		26
Total restructuring and other charges	$	348	$	64

Employee severance and benefit arrangements includes a charge of $129 million in Q1 2024 relating to actions taken to streamline operations and to reduce costs.

Asset impairment charges includes a goodwill impairment loss of $222 million in Q1 2024 related to our new Intel Foundry reporting unit. Refer to "Note 2: Operating Segments" within Notes to Consolidated Condensed Financial Statements for further information.

MD&A 33

Gains (Losses) on Equity Investments and Interest and Other, Net

(In Millions)	Q1 2024		Q1 2023
Ongoing mark-to-market adjustments on marketable equity securities	$	(91)	$	188
Observable price adjustments on non-marketable equity securities	24		10
Impairment charges	(69)		(36)
Sale of equity investments and other	341		7
Total gains (losses) on equity investments, net	$	205	$	169
Interest and other, net	$	145	$	141

Ongoing mark-to-market adjustments for Q1 2024 were primarily driven by our interests in Astera Labs, Inc and Montage Technology Co., Ltd; Q1 2023 was primarily related to our interest in Montage Technology Co., Ltd and others.

In Q1 2024, we recognized a $336 million initial fair value adjustment within sale of equity investments and other upon Astera Labs, Inc shares becoming marketable.

Provision for (Benefit from) Taxes

(In Millions)	Q1 2024			Q1 2023
Income (loss) before taxes	$	(719)		$	(1,158)
Provision for (benefit from) taxes	$	(282)		$	1,610
Effective tax rate	39.2		%	(139.0)		%

In Q1 2024, we recognized a benefit from taxes as we applied our year-to-date actual effective tax rate to our year-to-date measure of ordinary income (loss) before taxes, which reflects our jurisdictional mix of ordinary income and losses.

Our provision for, or benefit from, income taxes for an interim period has historically been determined using an estimated annual effective tax rate, adjusted for discrete items, if any. Under certain circumstances where we are unable to make a reliable estimate of the annual effective tax rate, we use the actual effective tax rate for the year-to-date period. In Q1 2024, we used the actual effective tax rate approach due to the variability of the rate as a result of fluctuations in forecasted income and the effects of being taxed in multiple tax jurisdictions.

MD&A 34

Liquidity and Capital Resources

We consider the following when assessing our liquidity and capital resources:

(In Millions)	Mar 30, 2024		Dec 30, 2023
Cash and cash equivalents	$	6,923	$	7,079
Short-term investments	14,388		17,955
Total cash and short-term investments	$	21,311	$	25,034
Total debt	$	52,450	$	49,266

We believe we have sufficient sources of funding to meet our business requirements for the next 12 months and in the longer term. Cash generated by operations, and total cash and short-term investments as shown in the preceding table, are our primary sources of liquidity for funding our strategic business requirements. These sources are further supplemented by our committed credit facilities and other borrowing capacity and certain other Smart Capital initiatives that we have undertaken. Our short-term funding requirements include capital expenditures for worldwide manufacturing and assembly and test, including investments in our process technology roadmap; working capital requirements; and potential acquisitions, strategic investments, and dividends. Our long-term funding requirements incrementally contemplate investments in significant manufacturing expansion plans and investments to accelerate our process technology.

Our total cash and short-term investments and related cash flows may be affected by certain discretionary actions we may take with customers and suppliers to accelerate or delay certain cash receipts or payments to manage liquidity for our strategic business requirements. These actions can include, among others, negotiating with suppliers to optimize our payment terms and conditions, adjusting the timing of cash flows associated with customer sales programs and collections, managing inventory levels and purchasing practices, and selling certain of our accounts receivables on a non-recourse basis to third party financial institutions.

We expect to continue to benefit from government incentives, and any incentives above our current expectations would enable us to increase the pace and size of our IDM 2.0 investments. Conversely, incentives below our expectations would increase our anticipated cash requirements and/or potentially curtail planned investments.

In April 2024 our Board of Directors declared a quarterly dividend of $0.125 per share on the company’s common stock, which will be payable on June 1, 2024, to stockholders of record as of May 7, 2024. Future declarations of dividends and the establishment of future record and payment dates are subject to the final determination of our Board of Directors.

In Q1 2024, we issued a total of $2.6 billion aggregate principal amount of senior notes for general corporate purposes, including, but not limited to, refinancing of outstanding debt and funding for working capital and capital expenditures. We also expanded both our 5-year $5.0 billion revolving credit facility agreement and our 364-day $5.0 billion credit facility agreement, to $7.0 billion and $8.0 billion, respectively, and the maturity dates were extended by one year to February 2029 and January 2025, respectively. We have other potential sources of liquidity including our commercial paper program and our automatic shelf registration statement on file with the SEC, pursuant to which we may offer an unspecified amount of debt, equity, and other securities. Under our commercial paper program, we have an ongoing authorization from our Board of Directors to borrow up to $10.0 billion. As of March 30, 2024, we had $793 million of commercial paper obligations outstanding. As of March 30, 2024, we had no outstanding borrowings on the revolving credit facilities.

We maintain a diverse investment portfolio that we continually analyze based on issuer, industry, and country. Substantially all of our investments in debt instruments were in investment-grade securities.

Cash flows from operating, investing and financing activities for Q1 2024 and Q1 2023 were as follows:

	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Net cash provided by (used for) operating activities	$	(1,223)	$	(1,785)
Net cash provided by (used for) investing activities	(2,563)		(8,521)
Net cash provided by (used for) financing activities	3,630		7,394
Net increase (decrease) in cash and cash equivalents	$	(156)	$	(2,912)

Operating Activities

Operating cash flows consist of net income adjusted for certain non-cash items and changes in certain assets and liabilities.

The decrease in cash used for operations in the first three months of 2024 was primarily driven by a lower net operating loss compared to the first three months of 2023, partially offset by certain cash unfavorable changes in working capital.

MD&A 35

Investing Activities

Investing cash flows consist primarily of capital expenditures; investment purchases, sales, maturities, and disposals; and proceeds from capital-related government incentives.

Cash used for investing activities was lower in the first three months of 2024 compared to the first three months of 2023, primarily due to lower purchases of short-term investments; lower additions to property, plant, and equipment; and increased proceeds from capital-related government incentives. These favorable cash impacts were partially offset by lower maturities and sales of short-term investments and certain other cash unfavorable investing activities during the first three months of 2024.

Financing Activities

Financing cash flows consist primarily of payment of dividends to stockholders, issuance and repayment of short-term and long-term debt, and proceeds from partner contributions and equity-related issuances.

Cash provided by financing activities was lower in the first three months of 2024 compared to the first three months of 2023. This decrease was primarily due to a reduction in net proceeds from our debt and commercial paper issuances, net of commercial paper repayments; partially offset by the cash favorable impacts of reduced dividend payments in the first three months of 2024.

MD&A 36

Non-GAAP Financial Measures

In addition to disclosing financial results in accordance with US GAAP, this document contains references to the non-GAAP financial measures below. We believe these non-GAAP financial measures provide investors with useful supplemental information about our operating performance, enable comparison of financial trends and results between periods where certain items may vary independent of business performance, and allow for greater transparency with respect to key metrics used by management in operating our business and measuring our performance. These non-GAAP financial measures are used in our performance-based RSUs and our cash bonus plans.

Our non-GAAP financial measures reflect adjustments based on one or more of the following items, as well as the related income tax effects. Income tax effects are calculated using a fixed long-term projected tax rate of 13% across all adjustments. We project this long-term non-GAAP tax rate on an annual basis using a five-year non-GAAP financial projection that excludes the income tax effects of each adjustment. The projected non-GAAP tax rate also considers factors such as our tax structure, our tax positions in various jurisdictions, and key legislation in significant jurisdictions where we operate. This long-term non-GAAP tax rate may be subject to change for a variety of reasons, including the rapidly evolving global tax environment, significant changes in our geographic earnings mix, or changes to our strategy or business operations. Management uses this non-GAAP tax rate in managing internal short- and long-term operating plans and in evaluating our performance; we believe this approach facilitates comparison of our operating results and provides useful evaluation of our current operating performance.

Our non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with US GAAP, and the financial results calculated in accordance with US GAAP and reconciliations from these results should be carefully evaluated.

Non-GAAP adjustment or measure	Definition	Usefulness to management and investors
Acquisition-related adjustments	Amortization of acquisition-related intangible assets consists of amortization of intangible assets such as developed technology, brands, and customer relationships acquired in connection with business combinations. Charges related to the amortization of these intangibles are recorded within both cost of sales and MG&A in our US GAAP financial statements. Amortization charges are recorded over the estimated useful life of the related acquired intangible asset, and thus are generally recorded over multiple years.	We exclude amortization charges for our acquisition-related intangible assets for purposes of calculating certain non-GAAP measures because these charges are inconsistent in size and are significantly impacted by the timing and valuation of our acquisitions. These adjustments facilitate a useful evaluation of our current operating performance and comparison to our past operating performance and provide investors with additional means to evaluate cost and expense trends.
Share-based compensation	Share-based compensation consists of charges related to our employee equity incentive plans.	We exclude charges related to share-based compensation for purposes of calculating certain non-GAAP measures because we believe these adjustments provide comparability to peer company results and because these charges are not viewed by management as part of our core operating performance. We believe these adjustments provide investors with a useful view, through the eyes of management, of our core business model, how management currently evaluates core operational performance, and additional means to evaluate expense trends, including in comparison to other peer companies.
Restructuring and other charges	Restructuring charges are costs associated with a restructuring plan and are primarily related to employee severance and benefit arrangements. Other charges include periodic goodwill and asset impairments, certain pension charges, and costs associated with restructuring activity.	We exclude restructuring and other charges, including any adjustments to charges recorded in prior periods, for purposes of calculating certain non-GAAP measures because these costs do not reflect our core operating performance. These adjustments facilitate a useful evaluation of our core operating performance and comparisons to past operating results and provide investors with additional means to evaluate expense trends.
(Gains) losses on equity investments, net	(Gains) losses on equity investments, net consists of ongoing mark-to-market adjustments on marketable equity securities, observable price adjustments on non-marketable equity securities, related impairment charges, and the sale of equity investments and other.	We exclude these non-operating gains and losses for purposes of calculating certain non-GAAP measures because it provides comparability between periods. The exclusion reflects how management evaluates the core operations of the business.

MD&A 37

(Gains) losses from divestiture	(Gains) losses are recognized at the close of a divestiture, or over a specified deferral period when deferred consideration is received at the time of closing. Based on our ongoing obligation under the NAND wafer manufacturing and sale agreement entered into in connection with the first closing of the sale of our NAND memory business on December 29, 2021, a portion of the initial closing consideration was deferred and will be recognized between first and second closing.	We exclude gains or losses resulting from divestitures for purposes of calculating certain non-GAAP measures because they do not reflect our current operating performance. These adjustments facilitate a useful evaluation of our current operating performance and comparisons to past operating results.
Adjusted free cash flow	We reference a non-GAAP financial measure of adjusted free cash flow, which is used by management when assessing our sources of liquidity, capital resources, and quality of earnings. Adjusted free cash flow is operating cash flow adjusted for (1) additions to property, plant, and equipment, net of proceeds from capital-related government incentives and partner contributions, and (2) payments on finance leases.	This non-GAAP financial measure is helpful in understanding our capital requirements and sources of liquidity by providing an additional means to evaluate the cash flow trends of our business.

Following are the reconciliations of our most comparable US GAAP measures to our non-GAAP measures presented:

	Three Months Ended
	Mar 30, 2024			Apr 1, 2023
Gross margin percentage	41.0		%	34.2		%
Acquisition-related adjustments	1.8		%	2.8		%
Share-based compensation	2.3		%	1.4		%
Non-GAAP gross margin percentage	45.1		%	38.4		%
Earnings (loss) per share attributable to Intel—diluted	$	(0.09)		$	(0.66)
Acquisition-related adjustments	0.06			0.09
Share-based compensation	0.28			0.18
Restructuring and other charges	0.08			0.01
(Gains) losses on equity investments, net	(0.05)			(0.04)
(Gains) losses from divestiture	(0.01)			(0.01)
Adjustments attributable to non-controlling interest	—			—
Income tax effects	(0.09)			0.39
Non-GAAP earnings (loss) per share attributable to Intel—diluted	$	0.18		$	(0.04)

	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Net cash provided by (used for) operating activities	$	(1,223)	$	(1,785)
Net additions to property, plant, and equipment	(4,955)		(6,964)
Payments on finance leases	—		(15)
Adjusted free cash flow	$	(6,178)	$	(8,764)
Net cash provided by (used for) investing activities	$	(2,563)	$	(8,521)
Net cash provided by (used for) financing activities	$	3,630	$	7,394

MD&A 38

Risk Factors and Other Key Information

Risk Factors

The risks described in "Risk Factors" within Other Key Information in our 2023 Form 10-K could materially and adversely affect our business, financial condition, and results of operations, and the trading price of our common stock could decline. These risk factors do not identify all risks that we face—our operations could also be affected by factors that are not presently known to us or that we currently consider to be immaterial to our operations. Due to risks and uncertainties, known and unknown, our past financial results may not be a reliable indicator of future performance and historical trends should not be used to anticipate results or trends in future periods. Refer also to the other information set forth in this Form 10-Q, including in the Forward-Looking Statements, MD&A, and the Consolidated Condensed Financial Statements and Supplemental Details sections.

Quantitative and Qualitative Disclosures About Market Risk

We are affected by changes in currency exchange and interest rates, as well as equity and commodity prices. Our risk management programs are designed to reduce, but may not entirely eliminate, the impacts of these risks. For a discussion about market risk and sensitivity analysis related to changes in currency exchange rates, interest rates, equity prices, and commodity prices refer to "Quantitative and Qualitative Disclosures About Market Risk" within MD&A in our 2023 Form 10-K.

Controls and Procedures

Inherent Limitations on Effectiveness of Controls

Our management, including the principal executive officer and principal financial officer, does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well-designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected.

Evaluation of Disclosure Controls and Procedures

Based on management’s evaluation (with the participation of our principal executive officer and principal financial officer), as of the end of the period covered by this report, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)), were effective to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended March 30, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Issuer Purchases of Equity Securities

We have an ongoing authorization, originally approved by our Board of Directors in 2005 and subsequently amended, to repurchase shares of our common stock in open market or negotiated transactions. No shares were repurchased during the quarter ending March 30, 2024. As of March 30, 2024, we were authorized to repurchase up to $110.0 billion, of which $7.2 billion remained available.

We issue RSUs as part of our equity incentive plans. In our Consolidated Condensed Financial Statements, we treat shares of common stock withheld for tax purposes on behalf of our employees in connection with the vesting of RSUs as common stock repurchases because they reduce the number of shares that would have been issued upon vesting. These withheld shares of common stock are not considered common stock repurchases under our authorized common stock repurchase program.

Rule 10b5-1 Trading Arrangements

Our directors and officers (as defined in Rule 16a-1 under the Exchange Act) may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. During the quarter ended March 30, 2024, no such plans or arrangements were adopted or terminated, including by modification.

Other Key Information 39

Disclosure Pursuant to Section 13(r) of the Securities Exchange Act of 1934

Section 13(r) of the Exchange Act requires an issuer to disclose certain information in its periodic reports if it or any of its affiliates knowingly engaged in certain activities, transactions, or dealings with individuals or entities subject to specific US economic sanctions during the reporting period, even when the activities, transactions, or dealings are conducted in compliance with applicable law. On March 2, 2021, the US Secretary of State designated the Federal Security Service of the Russian Federation (FSB) as a party subject to one such sanction. Though Intel has suspended sales in Russia, there may be a need to file documents or engage with FSB as Intel winds up our local Russian offices. All such dealings are explicitly authorized by General License 1B issued by the US Department of the Treasury’s Office of Foreign Assets Control (OFAC), and there are no gross revenues or net profits directly associated with any such dealings by us with the FSB.

On April 15, 2021, the US Department of the Treasury designated Pozitiv Teknolodzhiz, AO (Positive Technologies), a Russian IT security firm, as a party subject to one of the sanctions specified in Section 13(r). Prior to the designation, we communicated with Positive Technologies regarding its IT security research and coordinated disclosure of security vulnerabilities identified by the firm. Based on a license issued by OFAC, we resumed such communications. There are no gross revenues or net profits directly associated with any such activities. We plan to continue these communications in accordance with the terms and conditions of the OFAC license.

Other Key Information 40

Exhibits

		Incorporated by Reference
Exhibit Number	Exhibit Description	Form	File Number	Exhibit	Filing Date	Filed or Furnished Herewith
3.1	Corrected Third Restated Certificate of Incorporation of Intel Corporation, dated October 23, 2023	10-Q	000-06217	3.1	10/27/2023
3.2	Intel Corporation Bylaws, as amended and restated on November 29, 2023	8-K	000-06217	3.2	12/5/2023
4.1	Twentieth Supplemental Indenture, dated as of February 21, 2024, between Intel Corporation and Computershare Trust Company, National Association (as successor to Wells Fargo Bank, National Association), as trustee	8-K	000-06217	4.1	2/21/2024
10.1†	Executive Officer Cash Severance Policy of Intel Corporation, dated February 16, 2024	8-K	000-06217	10.1	2/16/2024
31.1	Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) of the Exchange Act					X
31.2	Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) of the Exchange Act					X
32.1	Certification of the Chief Executive Officer and the Chief Financial Officer pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350					X
101	Inline XBRL Document Set for the consolidated condensed financial statements and accompanying notes in Consolidated Condensed Financial Statements and Supplemental Details					X
104	Cover Page Interactive Data File - formatted in Inline XBRL and included as Exhibit 101					X

† Management contracts or compensation plans or arrangements in which directors or executive officers are eligible to participate.

Other Key Information 41

Form 10-Q Cross-Reference Index

Item Number	Item
Part I - Financial Information
Item 1.	Financial Statements	Pages 4 - 23
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations:
	Liquidity and capital resources	Pages 35 - 36
	Results of operations	Pages 3, 24 - 34
	Critical accounting estimates	Page 24
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	Page 39
Item 4.	Controls and Procedures	Page 39
Part II - Other Information
Item 1.	Legal Proceedings	Pages 19 - 23
Item 1A.	Risk Factors	Page 39
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	Page 39
Item 3.	Defaults Upon Senior Securities	Not applicable
Item 4.	Mine Safety Disclosures	Not applicable
Item 5.	Other Information
	Rule 10b5-1 Trading Arrangements	Page 39
	Disclosure Pursuant to Section 13(r) of the Securities Exchange Act of 1934	Page 40
Item 6.	Exhibits	Page 41
Signatures		Page 43

Other Key Information 42

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		INTEL CORPORATION (Registrant)
Date:	April 25, 2024	By:	/s/ DAVID ZINSNER
			David Zinsner
			Executive Vice President, Chief Financial Officer, and Principal Financial Officer
Date:	April 25, 2024	By:	/s/ SCOTT GAWEL
			Scott Gawel
			Corporate Vice President, Chief Accounting Officer, and Principal Accounting Officer

43

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Patrick P. Gelsinger, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Intel Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	April 25, 2024	By:	/s/ PATRICK P. GELSINGER
			Patrick P. Gelsinger
			Chief Executive Officer, Director and Principal Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, David Zinsner, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Intel Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	April 25, 2024	By:	/s/ DAVID ZINSNER
			David Zinsner
			Executive Vice President, Chief Financial Officer and Principal Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION

Each of the undersigned hereby certifies, for the purposes of section 1350 of chapter 63 of title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Intel Corporation (Intel), that, to his knowledge, the Quarterly Report of Intel on Form 10-Q for the period ended March 30, 2024, fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Intel. This written statement is being furnished to the Securities and Exchange Commission as an exhibit to such Form 10-Q. A signed original of this statement, which may be electronic, has been provided to Intel and will be retained by Intel and furnished to the Securities and Exchange Commission or its staff upon request.

Date:	April 25, 2024	By:	/s/ PATRICK P. GELSINGER
			Patrick P. Gelsinger
			Chief Executive Officer, Director and Principal Executive Officer
Date:	April 25, 2024	By:	/s/ DAVID ZINSNER
			David Zinsner
			Executive Vice President, Chief Financial Officer, and Principal Financial Officer

XML

Cover Page - shares shares in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 19, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 30, 2024
Entity File Number	000-06217
Entity Registrant Name	INTEL CORPORATION
Entity Central Index Key	0000050863
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	94-1672743
Entity Address, Address Line One	2200 Mission College Boulevard,
Entity Address, City or Town	Santa Clara,
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95054-1549
City Area Code	(408)
Local Phone Number	765-8080
Title of 12(b) Security	Common stock, $0.001 par value
Trading Symbol	INTC
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		4,257

XML

Consolidated Condensed Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Income Statement [Abstract]
Net revenue	$ 12,724	$ 11,715
Cost of sales	7,507	7,707
Gross margin	5,217	4,008
Research and development	4,382	4,109
Marketing, general, and administrative	1,556	1,303
Restructuring and other charges	348	64
Operating expenses	6,286	5,476
Operating income (loss)	(1,069)	(1,468)
Gains (losses) on equity investments, net	205	169
Interest and other, net	145	141
Income (loss) before taxes	(719)	(1,158)
Provision for (benefit from) taxes	(282)	1,610
Net income (loss)	(437)	(2,768)
Less: Net income (loss) attributable to non-controlling interests	(56)	(10)
Net income (loss) attributable to Intel	$ (381)	$ (2,758)
Earnings per share - Basic (in dollars per share)	$ (0.09)	$ (0.66)
Earnings per share - Diluted (in dollars per share)	$ (0.09)	$ (0.66)
Weighted average shares of common stock outstanding:
Basic (shares)	4,242	4,154
Diluted (shares)	4,242	4,154

XML

Consolidated Condensed Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ (437)	$ (2,768)
Changes in other comprehensive income, net of tax:
Net unrealized holding gains (losses) on derivatives	(328)	142
Actuarial valuation and other pension benefits (expenses), net	0	1
Translation adjustments and other	1	0
Other comprehensive income (loss)	(327)	143
Total comprehensive income (loss)	(764)	(2,625)
Less: comprehensive income (loss) attributable to non-controlling interests	(56)	(10)
Total comprehensive income (loss)	$ (708)	$ (2,615)

XML

Consolidated Condensed Balance Sheets - USD ($) $ in Millions	Mar. 30, 2024	Dec. 30, 2023
Current assets:
Cash and cash equivalents	$ 6,923	$ 7,079
Short-term investments	14,388	17,955
Accounts receivable, net	3,323	3,402
Inventories	11,494	11,127
Other current assets	6,480	3,706
Total current assets	42,608	43,269
Property, plant, and equipment, net of accumulated depreciation of $99,315 ($98,010 as of December 30, 2023)	99,924	96,647
Equity Investments	6,139	5,829
Goodwill	27,440	27,591
Identified intangible assets, net	4,675	4,589
Other long-term assets	11,947	13,647
Total assets	192,733	191,572
Current liabilities:
Short-term debt	4,581	2,288
Accounts payable	8,559	8,578
Accrued compensation and benefits	2,506	3,655
Income taxes payable	346	1,107
Other accrued liabilities	11,221	12,425
Total current liabilities	27,213	28,053
Debt	47,869	46,978
Other long-term liabilities	6,895	6,576
Contingencies (Note 13)
Stockholders’ equity:
Common stock and capital in excess of par value, 4,257 issued and outstanding (4,228 issued and outstanding as of December 30, 2023)	38,291	36,649
Accumulated other comprehensive income (loss)	(542)	(215)
Retained earnings	68,224	69,156
Total stockholders' equity	105,973	105,590
Non-controlling interest	4,783	4,375
Accumulated other comprehensive income (loss)	110,756	109,965
Total liabilities and stockholders’ equity	$ 192,733	$ 191,572

XML

Consolidated Condensed Balance Sheets (Parenthetical) - USD ($) shares in Millions, $ in Millions	Mar. 30, 2024	Dec. 30, 2023
Assets
Accumulated depreciation	$ 99,315	$ 98,010
Stockholders’ equity:
Common stock, shares issued	4,257	4,228
Common stock, shares outstanding	4,257	4,228

XML

Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Statement of Cash Flows [Abstract]
Cash and cash equivalents, beginning of period	$ 7,079	$ 11,144
Cash flows provided by (used for) operating activities:
Net income (loss)	(437)	(2,768)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation	2,200	1,901
Share-based compensation	1,179	739
Restructuring and other charges	348	55
Amortization of intangibles	351	465
(Gains) losses on equity investments, net	(208)	(167)
Changes in assets and liabilities:
Accounts receivable	80	286
Inventories	(366)	231
Accounts payable	(386)	(771)
Accrued compensation and benefits	(1,289)	(1,560)
Income taxes	(591)	1,344
Other assets and liabilities	(2,104)	(1,540)
Total adjustments	(786)	983
Net cash provided by operating activities	(1,223)	(1,785)
Cash flows provided by (used for) investing activities:
Additions to property, plant and equipment	(5,970)	(7,413)
Proceeds from capital-related government incentives	592	0
Purchases of short-term investments	(6,460)	(16,132)
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale	9,598	14,173
Other investing	(323)	851
Net cash used for investing activities	(2,563)	(8,521)
Cash flows provided by (used for) financing activities:
Issuance of commercial paper, net of issuance costs	793	0
Repayment of commercial paper	0	(2,930)
Payments on finance leases	0	(15)
Partner contributions	423	449
Issuance of long-term debt, net of issuance costs	2,537	10,968
Proceeds from sales of common stock through employee equity incentive plans	626	659
Payment of dividends to stockholders	(529)	(1,512)
Other financing	(220)	(225)
Net cash provided by (used for) financing activities	3,630	7,394
Net increase (decrease) in cash and cash equivalents	(156)	(2,912)
Cash and cash equivalents, end of period	6,923	8,232
Supplemental disclosures:
Acquisition of property, plant, and equipment included in accounts payable and accrued liabilities	5,167	4,711
Interest, net of capitalized interest	540	239
Income taxes, net of refunds	$ 315	$ 267

XML

Consolidated Condensed Statements of Stockholders' Equity - USD ($) shares in Millions, $ in Millions	Total	Common Stock and Capital in Excess of Par Value	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Noncontrolling Interest
Common stock, shares outstanding, beginning (in shares) at Dec. 31, 2022		4,137
Total stockholders' equity, beginning at Dec. 31, 2022	$ 103,286	$ 31,580	$ (562)	$ 70,405	$ 1,863
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(2,768)			(2,758)	(10)
Other comprehensive income (loss)	143		143
Net proceeds from partner contributions	449				449
Employee equity incentive plans and other (in shares)		36
Employee equity incentive plans and other	659	$ 659
Share-based compensation	739	$ 697			42
Restricted stock unit withholdings (in shares)		(2)
Restricted stock unit withholdings	(69)	$ (107)		38
Cash dividends declared	(2,036)			(2,036)
Common stock, shares outstanding, ending (in shares) at Apr. 01, 2023		4,171
Total stockholders' equity, ending at Apr. 01, 2023	$ 100,403	$ 32,829	(419)	65,649	2,344
Common stock, shares outstanding, beginning (in shares) at Dec. 30, 2023	4,228	4,228
Total stockholders' equity, beginning at Dec. 30, 2023	$ 109,965	$ 36,649	(215)	69,156	4,375
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(437)			(381)	(56)
Other comprehensive income (loss)	(327)		(327)
Net proceeds from partner contributions	423	$ 0			423
Employee equity incentive plans and other (in shares)		32
Employee equity incentive plans and other	626	$ 626
Share-based compensation	1,179	$ 1,138			41
Restricted stock unit withholdings (in shares)		(3)
Restricted stock unit withholdings	(144)	$ (122)		(22)
Cash dividends declared	$ (529)			(529)
Common stock, shares outstanding, ending (in shares) at Mar. 30, 2024	4,257	4,257
Total stockholders' equity, ending at Mar. 30, 2024	$ 110,756	$ 38,291	$ (542)	$ 68,224	$ 4,783

XML

Consolidated Condensed Statements of Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Retained Earnings
Cash dividends declared (in dollars per share)	$ 0.13	$ 0.49

XML

Basis of Presentation

3 Months Ended

Mar. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Note 1 : Basis of Presentation

We prepared our interim Consolidated Condensed Financial Statements that accompany these notes in conformity with US GAAP, consistent in all material respects with those applied in our 2023 Form 10-K.

We have made estimates and judgments affecting the amounts reported in our Consolidated Condensed Financial Statements and the accompanying notes. The actual results that we experience may differ materially from our estimates. The interim financial information is unaudited, and reflects all normal adjustments that are, in our opinion, necessary to provide a fair statement of results for the interim periods presented. This report should be read in conjunction with our 2023 Form 10-K where we include additional information on our critical accounting estimates, policies, and the methods and assumptions used in our estimates.

XML

Operating Segments

3 Months Ended

Mar. 30, 2024

Segment Reporting [Abstract]

Operating Segments

Note 2 : Operating Segments

We previously announced the implementation of our internal foundry operating model, which took effect in the first quarter of 2024, and creates a foundry relationship between our Intel Products business (collectively CCG, DCAI, and NEX) and our Intel Foundry business. Intel Products consists substantially of design and development of CPUs and related solutions for third party customers. Intel Foundry consists substantially of process engineering, manufacturing, and foundry services groups that provide manufacturing, test, and assembly services to our Intel Products business and to third party customers. Both businesses utilize marketing, sales, and other support functions.

Our internal foundry model is a key component of our strategy and is designed to reshape our operational dynamics and drive greater transparency, accountability, and focus on costs and efficiency. We also previously announced our intent to operate Altera, an Intel Company (previously Intel's Programmable Solutions Group), as a standalone business, with segment reporting beginning in the first quarter of 2024. Altera was previously included in our DCAI segment results. As a result of these changes, we modified our segment reporting in the first quarter of 2024 to align to this new operating model. All prior period segment data has been retrospectively adjusted to reflect the way our Chief Operating Decision Maker (CODM) internally receives information and manages and monitors our operating segment performance starting in fiscal year 2024. There are no changes to our consolidated financial statements for any prior periods.

We organize our business as follows:

▪Intel Products:

▪Client Computing Group (CCG)

▪Data Center and AI (DCAI)

▪Network and Edge (NEX)

▪Intel Foundry

▪All other

▪Altera

▪Mobileye

▪Other

CCG, DCAI, and Intel Foundry qualify as reportable operating segments. NEX, Altera, and Mobileye do not qualify as reportable operating segments; however, we have elected to disclose their results. When we enter into federal contracts, they are aligned to the sponsoring operating segment.

The accounting policies for our segment reporting are the same for Intel as a whole. A summary of the basis for which we report our operating segment revenues and operating margin is as follows:

Intel Products: CCG, DCAI, and NEX

▪Segment revenue: consists of revenues from third party customers. The Intel Products operating segments represent a substantial majority of Intel consolidated revenue and are derived from our principal products that incorporate various components and technologies, including a microprocessor and chipset, a stand-alone SoC, or a multichip package, which are based on Intel architecture.

▪Segment expenses: consists of intersegment charges for product manufacturing and related services from Intel Foundry, external foundry and other manufacturing, product development costs, allocated expenses as described below, and direct operating expenses.

Intel Foundry

▪Segment revenue: consists substantially of intersegment product and services revenue for wafer fabrication and related products and services sold to Intel Products, Altera, and certain other Intel internal businesses. We recognize intersegment revenue when we satisfy performance obligations as evidenced by the transfer of control of Intel Foundry products and services to the Intel Products businesses, which is generally at the completion of wafer sorting and at the completion of assembly and test services. Intersegment sales are recorded at prices that are intended to approximate market pricing. Intel Foundry also includes certain third party foundry and assembly and test revenues from external customers that were $27 million in first three months of 2024 and $118 million in the first three months of 2023.

▪Segment expenses: consists of direct expenses for technology development, product manufacturing and services provided by Intel Foundry to internal and external customers, allocated expenses as described below, and direct operating expenses. Direct expenses for product manufacturing includes excess capacity charges that were previously allocated primarily to CCG, DCAI, and NEX.

All other: Altera & Mobileye

▪Segment revenue: consists of product revenues from third party customers. Altera revenue is derived from programmable semiconductors, primarily FPGAs, CPLDs, acceleration platforms, software, IP, and related products. Mobileye revenue is derived from advanced driver-assistance systems (ADAS) and autonomous driving technologies and solutions.

▪Segment expenses: Altera expenses consist of intersegment charges for product manufacturing and related services from Intel Foundry, third party manufacturing, allocated expenses as described below, and direct operating expenses. Mobileye expenses consists of third party direct expenses for product manufacturing and related services for the manufacturing of Mobileye products and direct operating expenses.

Our "all other" category also consists of "other", which includes:

▪results of operations from non-reportable segments not otherwise presented, and from start-up businesses that support our initiatives; and

▪historical results of operations from divested businesses.

We allocate operating expenses from our sales and marketing group to the Intel Products operating segments, and allocate operating expenses from our finance and administration groups to all of our operating segments, except Mobileye. Previously, operating expense from all of these groups as well as manufacturing and engineering, were generally allocated to all the operating segments, except Mobileye.

We estimate that the substantial majority of our consolidated depreciation expense was incurred by Intel Foundry in the first three months of 2024 and in the first three months of 2023. Intel Foundry depreciation expense is substantially included in overhead cost pools and then combined with other costs, and subsequently absorbed into inventory as each product passes through the manufacturing process and is sold to Intel Products and other customers. As a result, it is impractical to determine the total depreciation expense included as a component of each Intel Products operating segment's operating income (loss) results.

We do not allocate to our operating segments corporate operating expenses that primarily consist of:

▪restructuring and other charges;

▪share-based compensation;

▪certain impairment charges; and

▪certain acquisition-related costs, including amortization and any impairment of acquisition-related intangibles and goodwill.

We do not allocate to our operating segments non-operating items such as:

▪gains and losses from equity investments;

▪interest and other income; and

▪income taxes.

The CODM, who is our CEO, allocates resources to and assesses the performance of each operating segment using information about the operating segment's revenue and operating income (loss). Although the CODM uses operating income (loss) to evaluate the segments, operating costs included in one segment may benefit other segments. The measures regularly provided to and used by our CODM under our new operating model continue to evolve; currently, our CODM does not regularly review or receive discrete asset information by segment.

Intersegment eliminations: Intersegment sales and related gross margin on inventory recorded at the end of the period or sold through to third party customers is eliminated for consolidation purposes. The Intel Products operating segments and Intel Foundry are meant to reflect separate fabless semiconductor and foundry companies. Thus certain intersegment activity is captured within the intersegment eliminations upon consolidation and presented at the Intel consolidated level. This activity primarily relates to inventory reserves which are determined and recorded based on our accounting policies for Intel as a whole, but are only recorded by the Intel Products operating segments upon transfer of inventory from Intel Foundry. If a reserve is identified prior to the related inventory transferring to Intel Products, that reserve is presented as activity within the intersegment eliminations.

Reporting units and goodwill reallocation: As a result of modifying our segment reporting in the first quarter of 2024, we reallocated goodwill among our affected reporting units on a relative fair value basis. We performed a quantitative goodwill impairment assessment for each of our reporting units immediately before and after our business reorganization. We concluded based on our pre-reorganization impairment test that goodwill was not impaired. As a result of our post-reorganization impairment test, we recognized a non-cash goodwill impairment loss of $222 million in the first three months of 2024 related to our new Intel Foundry reporting unit as the estimated fair value of the new reporting unit was lower than the assigned carrying value, which now includes substantially all of our allocated property, plant, and equipment. The Intel Foundry reporting unit has no remaining goodwill. The fair value substantially exceeded the carrying value for all remaining reporting units tested as part of our post-reorganization impairment test.

Operating segment and consolidated net revenue and operating income (loss) for each period were as follows:

	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Operating segment revenue:
Intel Products:
Client Computing Group
Desktop	$	2,461	$	1,879
Notebook	4,681		3,407
Other	391		481
	7,533		5,767
Data Center and AI	3,036		2,901
Network and Edge	1,364		1,489
Total Intel Products revenue	$	11,933	$	10,157
Intel Foundry	$	4,369	$	4,831
All other
Altera	342		816
Mobileye	239		458
Other	194		166
Total all other revenue	775		1,440
Total operating segment revenue	$	17,077	$	16,428
Intersegment eliminations	(4,353)		(4,713)
Total net revenue	$	12,724	$	11,715
Segment operating income (loss):
Intel Products:
Client Computing Group	$	2,645	$	1,180
Data Center and AI	482		22
Network and Edge	184		(69)
Total Intel Products operating income (loss)	$	3,311	$	1,133
Intel Foundry	$	(2,474)	$	(2,360)
All Other
Altera	(39)		290
Mobileye	(68)		123
Other	(105)		(66)
Total all other operating income (loss)	(212)		347
Total segment operating income (loss)	$	625	$	(880)
Intersegment eliminations	494		456
Corporate unallocated expenses	(2,188)		(1,044)
Total operating income (loss)	$	(1,069)	$	(1,468)

Corporate Unallocated Expenses

Corporate unallocated expenses represent costs incurred that are not directly attributed to an operating segment. The nature of these expenses may vary, but primarily consist of restructuring and other charges, share-based compensation, certain impairment charges, and certain acquisition-related costs.

	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Acquisition-related adjustments	$	(265)	$	(371)
Share-based compensation	(1,179)		(739)
Restructuring and other charges	(348)		(64)
Other	(396)		130
Total corporate unallocated expenses	$	(2,188)	$	(1,044)

XML

Non-Controlling Interests

3 Months Ended

Mar. 30, 2024

Noncontrolling Interest [Abstract]

Non-Controlling Interests

Note 3 : Non-Controlling Interests

	Mar 30, 2024				Dec 30, 2023
(In Millions)	Non-Controlling Interests		Non-Controlling Ownership %		Non-Controlling Interests		Non-Controlling Ownership %
Arizona Fab LLC	$	2,760	49	%	$	2,359	49	%
Mobileye	1,854		12	%	1,838		12	%
IMS Nanofabrication	169		32	%	178		32	%
Non-controlling interests	$	4,783			$	4,375

Semiconductor Co-Investment Program

In 2022, we closed a transaction with Brookfield Asset Management (Brookfield) resulting in the formation of Arizona Fab LLC (Arizona Fab). We consolidate the results of Arizona Fab, a VIE, into our consolidated financial statements because we are the primary beneficiary. Generally, contributions will be made to, and distributions will be received from Arizona Fab based on both parties' proportional ownership. We will be the sole operator and main beneficiary of two new chip factories that will be constructed by Arizona Fab, and we will have the right to purchase 100% of the related factory output. Once production commences, we will be required to operate Arizona Fab at minimum production levels measured in wafer starts per week and will be required to limit excess inventory held on site or we will be subject to certain penalties.

We have an unrecognized commitment to fund our respective share of the total construction costs of Arizona Fab of $29.0 billion.

As of March 30, 2024, substantially all of the assets of Arizona Fab consisted of property, plant, and equipment. The assets held by Arizona Fab, which can be used only to settle obligations of the VIE and are not available to us, were $5.6 billion as of March 30, 2024 ($4.8 billion as of December 30, 2023).

Mobileye

In 2022, Mobileye completed its IPO and certain other equity financing transactions. During 2023, we converted 38.5 million of our Mobileye Class B shares into Class A shares, representing 5% of Mobileye's outstanding capital stock, and subsequently sold the Class A shares for $42 per share as part of a secondary offering, receiving net proceeds of $1.6 billion and increasing our capital in excess of par value by $663 million, net of tax. We continue to consolidate the results of Mobileye into our consolidated financial statements.

IMS Nanofabrication

In 2023, we closed agreements to sell a combined 32% minority stake in our IMS business, a business within our Intel Foundry operating segment —including a 20% stake to Bain Capital and a 10% stake to Taiwan Semiconductor Manufacturing Company. Net proceeds resulting from the minority stake sales totaled $1.4 billion, and our capital in excess of par value increased by $958 million, net of tax. We continue to consolidate the results of IMS into our consolidated financial statements.

XML

Earnings Per Share

3 Months Ended

Mar. 30, 2024

Earnings Per Share [Abstract]

Earnings Per Share

Note 4 : Earnings (Loss) Per Share

We computed basic earnings (loss) per share of common stock based on the weighted average number of shares of common stock outstanding during the period. We computed diluted earnings (loss) per share of common stock based on the weighted average number of shares of common stock outstanding plus potentially dilutive shares of common stock outstanding during the period.

	Three Months Ended
(In Millions, Except Per Share Amounts)	Mar 30, 2024		Apr 1, 2023
Net income (loss)	$	(437)	$	(2,768)
Less: Net income (loss) attributable to non-controlling interests	(56)		(10)
Net income (loss) attributable to Intel	(381)		(2,758)
Weighted average shares of common stock outstanding—basic	4,242		4,154
Weighted average shares of common stock outstanding—diluted	4,242		4,154
Earnings (loss) per share attributable to Intel—basic	$	(0.09)	$	(0.66)
Earnings (loss) per share attributable to Intel—diluted	$	(0.09)	$	(0.66)

Potentially dilutive shares of common stock from employee equity incentive plans are determined by applying the treasury stock method to the assumed exercise of outstanding stock options, the assumed vesting of outstanding RSUs, and the assumed issuance of common stock under the stock purchase plan.

Due to our net losses in the three months ended March 30, 2024 and April 1, 2023, the assumed exercise of outstanding stock options, the assumed vesting of outstanding RSUs, and the assumed issuance of common stock under the stock purchase plan had an anti-dilutive effect on diluted loss per share for the period and were excluded from the computation of diluted loss per share.

XML

Other Financial Statement Details

3 Months Ended

Mar. 30, 2024

Other Financial Statement Details [Abstract]

Other Financial Statement Details

Note 5 : Other Financial Statement Details

Accounts Receivable

We sell certain of our accounts receivable on a non-recourse basis to third-party financial institutions. We record these transactions as sales of receivables and present cash proceeds as cash provided by operating activities in the Consolidated Condensed Statements of Cash Flows. Accounts receivable sold under non-recourse factoring arrangements were $500 million during the first three months of 2024 ($500 million in the first three months of 2023). After the sale of our accounts receivable, we expect to collect payment from the customers and remit it to the third-party financial institution.

Inventories

(In Millions)	Mar 30, 2024		Dec 30, 2023
Raw materials	$	1,209	$	1,166
Work in process	6,560		6,203
Finished goods	3,725		3,758
Total inventories	$	11,494	$	11,127

Other Accrued Liabilities

Other accrued liabilities include deferred compensation of $2.9 billion as of March 30, 2024 ($2.9 billion as of December 30, 2023).

Interest and Other, Net

	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Interest income	$	323	$	334
Interest expense	(258)		(193)
Other, net	80		—
Total interest and other, net	$	145	$	141

Interest expense is net of $363 million of interest capitalized in the first three months of 2024 ($363 million in the first three months of 2023).

XML

Restructuring and Other Charges

3 Months Ended

Mar. 30, 2024

Restructuring and Related Activities [Abstract]

Restructuring and Other Charges

Note 6 : Restructuring and Other Charges

	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Employee severance and benefit arrangements	$	129	$	(39)
Litigation charges and other	—		77
Asset impairment charges	219		26
Total restructuring and other charges	$	348	$	64

Employee severance and benefit arrangements includes a charge of $129 million in the first quarter of 2024 relating to actions taken to streamline operations and to reduce costs. We expect these actions to be substantially completed by the third quarter of 2024, but this is subject to change. Any changes to the estimates or timing will be reflected in our results of operations.

Asset impairment charges includes a goodwill impairment loss of $222 million in the first quarter of 2024 related to our new Intel Foundry reporting unit. Refer to "Note 2: Operating Segments" within Notes to Consolidated Condensed Financial Statements for further information on our business reorganization and goodwill impairment.

XML

Income Taxes

3 Months Ended

Mar. 30, 2024

Income Tax Disclosure [Abstract]

Income Taxes

Note 7 : Income Taxes

	Three Months Ended
(In Millions)	Mar 30, 2024			Apr 1, 2023
Income (loss) before taxes	$	(719)		$	(1,158)
Provision for (benefit from) taxes	$	(282)		$	1,610
Effective tax rate	39.2		%	(139.0)		%

Our provision for, or benefit from, income taxes for an interim period has historically been determined using an estimated annual effective tax rate, adjusted for discrete items, if any. Under certain circumstances where we are unable to make a reliable estimate of the annual effective tax rate, we use the actual effective tax rate for the year-to-date period. During the first quarter of 2024, we used the actual effective tax rate approach due to the variability of the rate as a result of fluctuations in forecasted income and the effects of being taxed in multiple tax jurisdictions.

XML

Investments

3 Months Ended

Mar. 30, 2024

Investments, Debt and Equity Securities [Abstract]

Investments

Note 8 : Investments

Short-term Investments

Short-term investments include marketable debt investments in corporate debt, government debt, and financial institution instruments, and are recorded within cash and cash equivalents and short-term investments on the Consolidated Condensed Balance Sheets. Government debt includes instruments such as non-US government bills and bonds and US agency securities. Financial institution instruments include instruments issued or managed by financial institutions in various forms, such as commercial paper, fixed- and floating-rate bonds, money market fund deposits, and time deposits. As of March 30, 2024, and December 30, 2023, substantially all time deposits were issued by institutions outside the US.

For certain of our marketable debt investments, we economically hedge market risks at inception with a related derivative instrument or the marketable debt investment itself is used to economically hedge currency exchange rate risk from remeasurement. These hedged investments are reported at fair value with gains or losses from the investments and the related derivative instruments recorded in interest and other, net. The fair value of our hedged investments was $13.8 billion as of March 30, 2024 ($17.1 billion as of December 30, 2023). For hedged investments still held at the reporting date, we recorded net losses of $307 million in the first three months of 2024 ($90 million of net gains in the first three months of 2023). We recorded net gains on the related derivatives of $345 million in the first three months of 2024 ($102 million of net losses in the first three months of 2023).

Our remaining unhedged marketable debt investments are reported at fair value, with unrealized gains or losses, net of tax, recorded in accumulated other comprehensive income (loss) and realized gains or losses recorded in interest and other, net. The adjusted cost of our unhedged investments was $4.0 billion as of March 30, 2024 ($4.7 billion as of December 30, 2023), which approximated the fair value for these periods.

The fair value of marketable debt investments, by contractual maturity, as of March 30, 2024, was as follows:

(In Millions)	Fair Value
Due in 1 year or less	$	5,579
Due in 1–2 years	2,457
Due in 2–5 years	6,915
Due after 5 years	433
Instruments not due at a single maturity date1	2,460
Total	$	17,844

1 Instruments not due at a single maturity date is comprised of money market fund deposits, which are classified as either short-term investments or cash and cash equivalents.

Equity Investments

(In Millions)	Mar 30, 2024		Dec 30, 2023
Marketable equity securities1	$	1,471	$	1,194
Non-marketable equity securities	4,664		4,630
Equity method investments	4		5
Total	$	6,139	$	5,829

1    Approximately 90% of our marketable equity securities are subject to trading-volume or market-based restrictions, which limit the number of shares we may sell in a specified period of time, impacting our ability to liquidate these investments. Certain of the trading volume restrictions generally apply for as long as we own more than 1% of the outstanding shares. Market-based restrictions result from the rules of the respective exchange.

The components of gains (losses) on equity investments, net for each period were as follows:

	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Ongoing mark-to-market adjustments on marketable equity securities	$	(91)	$	188
Observable price adjustments on non-marketable equity securities	24		10
Impairment charges	(69)		(36)
Sale of equity investments and other1	341		7
Total gains (losses) on equity investments, net	$	205	$	169

1 Sale of equity investments and other includes initial fair value adjustments recorded upon a security becoming marketable, realized gains (losses) on sales of non-marketable equity investments and equity method investments, and our share of equity method investee gains (losses) and distributions.

XML

Divestitures

3 Months Ended

Mar. 30, 2024

Business Combinations [Abstract]

Divestitures

Note 9 : Divestitures

NAND Memory Business

The NAND memory business included our NAND memory technology and manufacturing business (the NAND OpCo Business), which we deconsolidated upon closing the first phase of our sale agreement with SK hynix Inc (SK hynix) on December 29, 2021. We have a receivable within other current assets for the remaining proceeds of $2.0 billion, which remains outstanding as of March 30, 2024 and will be received upon the second closing of the transaction, expected to be in March 2025.

The wafer manufacturing and sale agreement includes incentives and penalties that are contingent on the cost of operation and output of the NAND OpCo Business. These incentives and penalties present a maximum exposure of up to $500 million annually, and $1.5 billion in the aggregate. We are currently in negotiations with SK hynix to update the operating plan of the NAND OpCo Business, which may impact the metrics associated with the incentives and penalties and our expectations of the performance of the NAND OpCo Business against those metrics.

We were reimbursed for costs that we incurred on behalf of the NAND OpCo Business for corporate function services, which include human resources, information technology, finance, supply chain, and other compliance requirements. We recorded a receivable related to these reimbursable costs due from the NAND OpCo Business, a deconsolidated entity, of $150 million within other current assets as of March 30, 2024 ($145 million recorded as of December 30, 2023).

XML

Borrowings

3 Months Ended

Mar. 30, 2024

Debt Disclosure [Abstract]

Borrowings

Note 10 : Borrowings

In the first quarter of 2024, we issued a total of $2.6 billion aggregate principal amount of senior notes. We also expanded both our 5-year $5.0 billion revolving credit facility agreement and our 364-day $5.0 billion credit facility agreement, to $7.0 billion and $8.0 billion, respectively, and the maturity dates were extended by one year to February 2029 and January 2025, respectively. The revolving credit facilities had no borrowings outstanding as of March 30, 2024.

We have an ongoing authorization from our Board of Directors to borrow up to $10.0 billion under our commercial paper program. We had $793 million of commercial paper outstanding as of March 30, 2024 (no commercial paper outstanding as of December 30, 2023).

Our senior fixed rate notes pay interest semiannually. We may redeem the fixed rate notes prior to their maturity at our option at specified redemption prices and subject to certain restrictions. The obligations under our senior fixed rate notes rank equally in the right of payment with all of our other existing and future senior unsecured indebtedness and effectively rank junior to all liabilities of our subsidiaries.

XML

Fair Value

3 Months Ended

Mar. 30, 2024

Fair Value Disclosures [Abstract]

Fair Value

Note 11 : Fair Value

Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis

	Mar 30, 2024								Dec 30, 2023
	Fair Value Measured and Recorded at Reporting Date Using								Fair Value Measured and Recorded at Reporting Date Using
(In Millions)	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Assets
Cash equivalents:
Corporate debt	$	—	$	231	$	—	$	231	$	—	$	769	$	—	$	769
Financial institution instruments¹	2,438		787		—		3,225		2,241		835		—		3,076
Reverse repurchase agreements	—		2,370		—		2,370		—		2,554		—		2,554
Short-term investments:
Corporate debt	—		6,298		—		6,298		—		6,951		—		6,951
Financial institution instruments¹	22		3,777		—		3,799		33		4,215		—		4,248
Government debt²	—		4,291		—		4,291		—		6,756		—		6,756
Other current assets:
Derivative assets	34		739		—		773		366		809		—		1,175
Marketable equity securities	1,471		—		—		1,471		1,194		—		—		1,194
Other long-term assets:
Derivative assets	—		6		—		6		—		21		—		21
Total assets measured and recorded at fair value	$	3,965	$	18,499	$	—	$	22,464	$	3,834	$	22,910	$	—	$	26,744
Liabilities
Other accrued liabilities:
Derivative liabilities	$	—	$	375	$	118	$	493	$	—	$	541	$	99	$	640
Other long-term liabilities:
Derivative liabilities	—		611		—		611		—		479		—		479
Total liabilities measured and recorded at fair value	$	—	$	986	$	118	$	1,104	$	—	$	1,020	$	99	$	1,119

1Level 1 investments consist of money market funds. Level 2 investments consist primarily of certificates of deposit, time deposits, commercial paper, notes and bonds issued by financial institutions.

2Level 2 investments consist primarily of non-US government debt.

Assets Measured and Recorded at Fair Value on a Non-Recurring Basis

Our non-marketable equity securities, equity method investments, and certain non-financial assets—such as intangible assets, goodwill, and property, plant, and equipment—are recorded at fair value only if an impairment or observable price adjustment is recognized in the current period. If an observable price adjustment or impairment is recognized on our non-marketable equity securities during the period, we classify these assets as Level 3.

Financial Instruments Not Recorded at Fair Value on a Recurring Basis

Financial instruments not recorded at fair value on a recurring basis include non-marketable equity securities and equity method investments that have not been remeasured or impaired in the current period, grants receivable, certain other receivables, and issued debt. We classify the fair value of grants receivable as Level 2. The estimated fair value of these financial instruments approximates their carrying value. The aggregate carrying value of grants receivable as of March 30, 2024 was $666 million (the aggregate carrying value as of December 30, 2023 was $559 million).

We classify the fair value of issued debt (excluding any commercial paper) as Level 2. The fair value of our issued debt was $48.7 billion as of March 30, 2024 ($47.6 billion as of December 30, 2023).

XML

Derivative Financial Instruments

3 Months Ended

Mar. 30, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

Note 12 : Derivative Financial Instruments

Volume of Derivative Activity

Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows: 

(In Millions)	Mar 30, 2024		Dec 30, 2023
Foreign currency contracts	$	27,942	$	30,064
Interest rate contracts	18,611		18,363
Other	2,507		2,103
Total	$	49,060	$	50,530

The total notional amount of outstanding pay-variable, receive-fixed interest rate swaps was $12.0 billion as of March 30, 2024 and December 30, 2023.

Fair Value of Derivative Instruments in the Consolidated Condensed Balance Sheets

	Mar 30, 2024				Dec 30, 2023
(In Millions)	Assets1		Liabilities2		Assets1		Liabilities2
Derivatives designated as hedging instruments:
Foreign currency contracts3	$	69	$	307	$	255	$	142
Interest rate contracts	—		723		—		578
Total derivatives designated as hedging instruments	$	69	$	1,030	$	255	$	720
Derivatives not designated as hedging instruments:
Foreign currency contracts3	$	391	$	65	$	314	$	363
Interest rate contracts	285		9		261		36
Equity contracts	34		—		366		—
Total derivatives not designated as hedging instruments	$	710	$	74	$	941	$	399
Total derivatives	$	779	$	1,104	$	1,196	$	1,119

1Derivative assets are recorded as other assets, current and long-term.

2Derivative liabilities are recorded as other liabilities, current and long-term.

3A substantial majority of these instruments mature within 12 months.

Amounts Offset in the Consolidated Condensed Balance Sheets

Agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows:

	Mar 30, 2024
							Gross Amounts Not Offset in the Balance Sheet
(In Millions)	Gross Amounts Recognized		Gross Amounts Offset in the Balance Sheet		Net Amounts Presented in the Balance Sheet		Financial Instruments		Cash and Non-Cash Collateral Received or Pledged		Net Amount
Assets:
Derivative assets subject to master netting arrangements	$	632	$	—	$	632	$	(350)	$	(282)	$	—
Reverse repurchase agreements	2,370		—		2,370		—		(2,370)		—
Total assets	$	3,002	$	—	$	3,002	$	(350)	$	(2,652)	$	—
Liabilities:
Derivative liabilities subject to master netting arrangements	$	1,097	$	—	$	1,097	$	(350)	$	(620)	$	127
Total liabilities	$	1,097	$	—	$	1,097	$	(350)	$	(620)	$	127

	Dec 30, 2023
							Gross Amounts Not Offset in the Balance Sheet
(In Millions)	Gross Amounts Recognized		Gross Amounts Offset in the Balance Sheet		Net Amounts Presented in the Balance Sheet		Financial Instruments		Cash and Non-Cash Collateral Received or Pledged		Net Amount
Assets:
Derivative assets subject to master netting arrangements	$	1,047	$	—	$	1,047	$	(617)	$	(430)	$	—
Reverse repurchase agreements	2,554		—		2,554		—		(2,554)		—
Total assets	$	3,601	$	—	$	3,601	$	(617)	$	(2,984)	$	—
Liabilities:
Derivative liabilities subject to master netting arrangements	$	1,111	$	—	$	1,111	$	(617)	$	(399)	$	95
Total liabilities	$	1,111	$	—	$	1,111	$	(617)	$	(399)	$	95

We obtain and secure available collateral from counterparties against obligations, including securities lending transactions and reverse repurchase agreements, when we deem it appropriate.

Derivatives in Cash Flow Hedging Relationships

The before-tax net gains or losses attributed to cash flow hedges recognized in other comprehensive income (loss) were $431 million net loss in the first three months of 2024 ($53 million net gains in the first three months of 2023). Substantially all of our cash flow hedges were foreign currency contracts for all periods presented.

During the first three months of 2024 and 2023, the amounts excluded from effectiveness testing were insignificant.

Derivatives in Fair Value Hedging Relationships    

The effects of derivative instruments designated as fair value hedges, recognized in interest and other, net for each period were as follows:

	Gains (Losses) on Derivatives Recognized in Consolidated Condensed Statements of Income
	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Interest rate contracts	$	(144)	$	192
Hedged items	144		(192)
Total	$	—	$	—

The amounts recorded on the Consolidated Condensed Balance Sheets related to cumulative basis adjustments for fair value hedges for each period were as follows:

Line Item in the Consolidated Condensed Balance Sheets in Which the Hedged Item is Included	Carrying Amount of the Hedged Item Assets/(Liabilities)				Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount Assets/(Liabilities)
(In Millions)	Mar 30, 2024		Dec 30, 2023		Mar 30, 2024		Dec 30, 2023
Long-term debt	$	(11,275)	$	(11,419)	$	722	$	578

Derivatives Not Designated as Hedging Instruments

The effects of derivative instruments not designated as hedging instruments on the Consolidated Condensed Statements of Income for each period were as follows:

		Three Months Ended
(In Millions)	Location of Gains (Losses) Recognized in Income on Derivatives	Mar 30, 2024		Apr 1, 2023
Foreign currency contracts	Interest and other, net	$	346	$	1
Interest rate contracts	Interest and other, net	117		(34)
Other	Various	137		115
Total		$	600	$	82

XML

Contingencies

3 Months Ended

Mar. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

Contingencies

Note 13 : Contingencies

Legal Proceedings

We are regularly party to various ongoing claims, litigation, and other proceedings, including those noted in this section. We have accrued a charge of $1.0 billion related to litigation involving VLSI and a charge of $401 million related to an EC-imposed fine, both as described below. Excluding the VLSI claims, management at present believes that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations, cash flows, or overall trends; however, legal proceedings and related government investigations are subject to inherent uncertainties, and unfavorable rulings, excessive verdicts, or other events could occur. Unfavorable resolutions could include substantial monetary damages, fines, or penalties. Certain of these outstanding matters include speculative, substantial, or indeterminate monetary awards. In addition, in matters for which injunctive relief or other conduct remedies are sought, unfavorable resolutions could include an injunction or other order prohibiting us from selling one or more products at all or in particular ways, precluding particular business practices, or requiring other remedies. An unfavorable outcome may result in a material adverse impact on our business, results of operations, financial position, and overall trends. We might also conclude that settling one or more such matters is in the best interests of our stockholders, employees, and customers, and any such settlement could include substantial payments. Unless specifically described below, we have not concluded that settlement of any of the legal proceedings noted in this section is appropriate at this time.

European Commission Competition Matter

In 2009, the EC found that we had used unfair business practices to persuade customers to buy microprocessors in violation of Article 82 of the EC Treaty (later renumbered Article 102) and Article 54 of the European Economic Area Agreement. In general, the EC found that we violated Article 82 by offering alleged “conditional rebates and payments” that required customers to purchase all or most of their x86 microprocessors from us and by making alleged “payments to prevent sales of specific rival products.” The EC ordered us to end the alleged infringement referred to in its decision and imposed a €1.1 billion fine, which we paid in the third quarter of 2009.

We appealed the EC decision to the European Court of Justice in 2014, after the General Court (then called the Court of First Instance) rejected our appeal of the EC decision in its entirety. In September 2017, the Court of Justice sent the case back to the General Court to examine whether the rebates at issue were capable of restricting competition. In January 2022, the General Court annulled the EC’s 2009 findings against us regarding rebates, as well as the €1.1 billion fine imposed on Intel, which was returned to us in February 2022. The General Court’s January 2022 decision did not annul the EC’s 2009 finding that we made payments to prevent sales of specific rival products.

In April 2022 the EC appealed the General Court’s decision to the Court of Justice. In addition, in September 2023 the EC imposed a €376 million ($401 million) fine against us based on its finding that we made payments to prevent sales of specific rival products. We have appealed the EC’s decision. We have accrued a charge for the fine and are unable to make a reasonable estimate of the potential loss or range of losses in excess of this amount given the procedural posture and the nature of these proceedings.

In a related matter, in April 2022 we filed applications with the General Court seeking an order requiring the EC to pay us approximately €593 million in default interest on the original €1.1 billion fine that was held by the EC for 12 years, which applications have been stayed pending the EC’s appeal of the General Court’s January 2022 decision.

Litigation Related to Security Vulnerabilities

In June 2017, a Google research team notified Intel and other companies that it had identified security vulnerabilities, the first variants of which are now commonly referred to as “Spectre” and “Meltdown,” that affect many types of microprocessors, including our products. As is standard when findings like these are presented, we worked together with other companies in the industry to verify the research and develop and validate software and firmware updates for impacted technologies. In January 2018, information on the security vulnerabilities was publicly reported, before software and firmware updates to address the vulnerabilities were made widely available.

As of April 24, 2024, consumer class action lawsuits against us were pending in the US and Canada. The plaintiffs, who purport to represent various classes of purchasers of our products, generally claim to have been harmed by our actions and/or omissions in connection with Spectre, Meltdown, and other variants of this class of security vulnerabilities that have been identified since 2018, and assert a variety of common law and statutory claims seeking monetary damages and equitable relief. In the US, class action suits filed in various jurisdictions between 2018 and 2021 were consolidated for all pretrial proceedings in the US District Court for the District of Oregon, which entered final judgment in favor of Intel in July 2022 based on plaintiffs’ failure to plead a viable claim. The Ninth Circuit Court of Appeals affirmed the district court’s judgment in November 2023, ending the litigation. In November 2023, new plaintiffs filed a consumer class action complaint in the US District Court for the Northern District of California with respect to a further vulnerability variant disclosed in August 2023 and commonly referred to as “Downfall.” We moved to dismiss that complaint in January 2024. In Canada, an initial status conference has not yet been scheduled in one case relating to Spectre and Meltdown pending in the Superior Court of Justice of Ontario, and a stay of a second case pending in the Superior Court of Justice of Quebec is in effect. In a class action relating to Spectre and Meltdown previously pending in Argentina, plaintiffs’ appeal of a May 2023 order dismissing their complaint for lack of standing was denied in February 2024, ending the lawsuit. Additional lawsuits and claims may be asserted seeking monetary damages or other related relief. Given the procedural posture and the nature of these cases, including that the pending proceedings are in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class or classes being certified or the ultimate size of any class or classes if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from these matters.

Litigation Related to 7nm Product Delay Announcement

Multiple securities class action lawsuits were filed in the US District Court for the Northern District of California against us and certain officers following our July 2020 announcement of 7nm product delays. The court consolidated the lawsuits and appointed lead plaintiffs in October 2020, and in January 2021 plaintiffs filed a consolidated complaint. Plaintiffs purport to represent all persons who purchased or otherwise acquired our common stock from October 25, 2019 through October 23, 2020, and they generally allege that defendants violated the federal securities laws by making false or misleading statements about the timeline for 7nm products. In March 2023, the district court granted the defendants’ motion to dismiss the consolidated complaint, and in April 2023 entered judgment. Plaintiffs appealed, and on April 19, 2024 the Ninth Circuit affirmed the judgment; the Ninth Circuit’s ruling is subject to appeal. Given the procedural posture and the nature of the case, including that it is in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class being certified or the ultimate size of any class if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from the matter. In July 2021, we introduced a new process node naming structure, and the 7nm process is now called Intel 4.

Litigation Related to Patent and IP Claims

We have had IP infringement lawsuits filed against us, including but not limited to those discussed below. Most involve claims that certain of our products, services, and technologies infringe others' IP rights. Adverse results in these lawsuits may include awards of substantial fines and penalties, costly royalty or licensing agreements, or orders preventing us from offering certain features, functionalities, products, or services. As a result, we may have to change our business practices, and develop non-infringing products or technologies, which could result in a loss of revenue for us and otherwise harm our business. In addition, certain agreements with our customers require us to indemnify them against certain IP infringement claims, which can increase our costs as a result of defending such claims, and may require that we pay significant damages, accept product returns, or supply our customers with non-infringing products if there were an adverse ruling in any such claims. In addition, our customers and partners may discontinue the use of our products, services, and technologies, as a result of injunctions or otherwise, which could result in loss of revenue and adversely affect our business.

VLSI Technology LLC v. Intel

In October 2017, VLSI Technology LLC (VLSI) filed a complaint against us in the US District Court for the Northern District of California alleging that various Intel FPGA and processor products infringe eight patents VLSI acquired from NXP Semiconductors, N.V. (NXP). Intel prevailed on all eight patents and the court entered final judgment in April 2024. Further appeals are possible. In April 2019, VLSI filed three infringement suits against us in the US District Court for the Western District of Texas accusing various of our processors of infringement of eight additional patents it had acquired from NXP:

▪The first Texas case went to trial in February 2021, and the jury awarded VLSI $1.5 billion for literal infringement of one patent and $675 million for infringement of another patent under the doctrine of equivalents. In April 2022, the court entered final judgment, awarding VLSI $2.1 billion in damages and approximately $162.3 million in pre-judgment and post-judgment interest. We appealed the judgment to the Federal Circuit Court of Appeals, including the court’s rejection of Intel’s claim to have a license from Fortress Investment Group’s acquisition of Finjan. The Federal Circuit Court heard oral argument in October 2023. In December 2023, the Federal Circuit reversed the finding of infringement as to the patent for which VLSI was awarded $675 million. The Federal Circuit affirmed the finding of infringement as to the patent for which VLSI had been awarded $1.5 billion, but vacated the damages award and sent the case back to the trial court for further damages proceedings on that patent. The Federal Circuit also ruled that Intel can advance the defense that it is licensed to VLSI’s patents. In December 2021 and January 2022 the Patent Trial and Appeal Board (PTAB) instituted Inter Partes Reviews (IPR) on the claims found to have been infringed in the first Texas case, and in May and June 2023 found all of those claims unpatentable; VLSI has appealed the PTAB’s decision. In March 2024, Intel filed a motion to stay the case pending appeals of the IPRs. In April 2024, Intel moved to add the defense that it is licensed to VLSI’s patents.

▪The second Texas case went to trial in April 2021, and the jury found that we do not infringe the asserted patents. VLSI had sought approximately $3.0 billion for alleged infringement, plus enhanced damages for willful infringement. The court has not yet entered final judgment.

▪The third Texas case went to trial in November 2022, with VLSI asserting one remaining patent. The jury found the patent valid and infringed, and awarded VLSI approximately $949 million in damages, plus interest and a running royalty. The court has not yet entered final judgment. In February 2023, we filed motions for a new trial and for judgment as a matter of law notwithstanding the verdict on various grounds. Further appeals are possible. In April 2024, Intel moved to add the defense that it is licensed to VLSI’s patents.

In May 2019, VLSI filed a case in Shenzhen Intermediate People’s Court against Intel, Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. VLSI asserted one patent against certain Intel Core processors. Defendants filed an invalidation petition in October 2019 with the China National Intellectual Property Administration (CNIPA) which held a hearing in September 2021. The Shenzhen court held trial proceedings in July 2021, and September 2023. VLSI sought an injunction as well as RMB 1.3 million in costs and expenses, but no damages. In September 2023, the CNIPA invalidated every claim of the asserted patent. In November 2023, the trial court dismissed VLSI’s case.

In May 2019, VLSI filed a case in Shanghai Intellectual Property Court against Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. asserting one patent against certain Intel core processors. The court held a trial hearing in December 2020, where VLSI requested expenses (RMB 300 thousand) and an injunction. In December 2022, we filed a petition to invalidate the patent at issue. The court held a second trial hearing in May 2022, and in October 2023, issued a decision finding no infringement and dismissing all claims. In November 2023, VLSI appealed the finding of non-infringement.

As of March 30, 2024, we have accrued a charge of approximately $1.0 billion related to the VLSI litigation. While we dispute VLSI’s claims and intend to vigorously defend against them, we are unable to make a reasonable estimate of losses in excess of recorded amounts given recent developments and future proceedings.

R2 Semiconductor Patent Litigation

In November 2022, R2 Semiconductor, Inc. (R2) filed a lawsuit in the High Court of Justice in the UK against Intel Corporation (UK) Limited and Intel Corporation, and a lawsuit in the Dusseldorf Regional Court in Germany against Intel Deutschland GmbH and certain Intel customers. R2 asserts one European patent is infringed by Intel’s Ice Lake, Tiger Lake, Alder Lake and Ice Lake Server (Xeon) processors (the accused products), and customer servers and laptops that contain those processors. R2 seeks an injunction in both actions prohibiting the sale and requiring the recall of the alleged infringing products. Intel is indemnifying its customers in the German lawsuit.

Intel disputes R2’s claims and intends to defend the lawsuits vigorously. In December 2022, Intel responded in the UK action that the asserted patent is not infringed and that the patent is invalid. In April 2023, defendants filed statements of defense in the German action that the asserted patent is not infringed and that an injunction would be a disproportionate remedy. In May 2023, defendants also filed a nullity action in the German Federal Patent Court on the ground that the asserted patent is invalid.

In December 2023, the German Federal Patent Court issued a preliminary opinion finding R2’s patent valid. The German Federal Patent Court’s final decision on invalidity is expected in October 2024. In December 2023, the court in Dusseldorf held a trial on the issue of infringement. In February 2024, the court found Intel’s processors infringe and issued an injunction and recall order against Intel and its customers. R2 has not yet sought to enforce the order. Intel has appealed the decision. In April 2024, Intel also filed a complaint with the Constitutional Court seeking a stay and a reversal of the finding of infringement and filed additional evidence with the appeals court to demonstrate that it does not infringe R2’s patent.

In March 2024, Intel filed an action in Milan, Italy seeking an order that it does not infringe R2’s patent.

In April 2024, R2 filed an action against Intel and its customers Dell, HP, and HPE for patent infringement in Paris, France. Intel and its customers have filed a nullity action against the patent in France.

Trial in the UK matter is scheduled for April 2024.

We are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from these lawsuits and the injunction and order of the Dusseldorf Regional Court due to the procedural posture and the nature of these cases, including that there are significant factual and legal issues to be resolved and that uncertainty exists as to, among other things: (i) whether and, if so, at what point in time the order in Germany may take effect, including as a result of a potential stay; (ii) whether and, if so, at what point we may be successful in appealing the decisions in Germany as to infringement and validity, (iii) the extent to which we and our customers are able to mitigate the impact of the injunction of the Dusseldorf Regional Court, (iv) the costs of recalling products if the recall order of the Dusseldorf Regional Court is enforced, (v) the extent to which R2 may be awarded damages, and (vi) the extent to which we may agree to compensate our customers for losses in connection with the injunction and recall and any potential damage award.

XML

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (381)	$ (2,758)

XML

Insider Trading Arrangements	3 Months Ended
	Mar. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

Operating Segments (Tables)

3 Months Ended

Mar. 30, 2024

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Operating segment and consolidated net revenue and operating income (loss) for each period were as follows:

	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Operating segment revenue:
Intel Products:
Client Computing Group
Desktop	$	2,461	$	1,879
Notebook	4,681		3,407
Other	391		481
	7,533		5,767
Data Center and AI	3,036		2,901
Network and Edge	1,364		1,489
Total Intel Products revenue	$	11,933	$	10,157
Intel Foundry	$	4,369	$	4,831
All other
Altera	342		816
Mobileye	239		458
Other	194		166
Total all other revenue	775		1,440
Total operating segment revenue	$	17,077	$	16,428
Intersegment eliminations	(4,353)		(4,713)
Total net revenue	$	12,724	$	11,715
Segment operating income (loss):
Intel Products:
Client Computing Group	$	2,645	$	1,180
Data Center and AI	482		22
Network and Edge	184		(69)
Total Intel Products operating income (loss)	$	3,311	$	1,133
Intel Foundry	$	(2,474)	$	(2,360)
All Other
Altera	(39)		290
Mobileye	(68)		123
Other	(105)		(66)
Total all other operating income (loss)	(212)		347
Total segment operating income (loss)	$	625	$	(880)
Intersegment eliminations	494		456
Corporate unallocated expenses	(2,188)		(1,044)
Total operating income (loss)	$	(1,069)	$	(1,468)

	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Acquisition-related adjustments	$	(265)	$	(371)
Share-based compensation	(1,179)		(739)
Restructuring and other charges	(348)		(64)
Other	(396)		130
Total corporate unallocated expenses	$	(2,188)	$	(1,044)

XML

Noncontrolling Interest (Tables)

3 Months Ended

Mar. 30, 2024

Noncontrolling Interest [Abstract]

Noncontrolling Interests

	Mar 30, 2024				Dec 30, 2023
(In Millions)	Non-Controlling Interests		Non-Controlling Ownership %		Non-Controlling Interests		Non-Controlling Ownership %
Arizona Fab LLC	$	2,760	49	%	$	2,359	49	%
Mobileye	1,854		12	%	1,838		12	%
IMS Nanofabrication	169		32	%	178		32	%
Non-controlling interests	$	4,783			$	4,375

XML

Earnings Per Share (Tables)

3 Months Ended

Mar. 30, 2024

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	Three Months Ended
(In Millions, Except Per Share Amounts)	Mar 30, 2024		Apr 1, 2023
Net income (loss)	$	(437)	$	(2,768)
Less: Net income (loss) attributable to non-controlling interests	(56)		(10)
Net income (loss) attributable to Intel	(381)		(2,758)
Weighted average shares of common stock outstanding—basic	4,242		4,154
Weighted average shares of common stock outstanding—diluted	4,242		4,154
Earnings (loss) per share attributable to Intel—basic	$	(0.09)	$	(0.66)
Earnings (loss) per share attributable to Intel—diluted	$	(0.09)	$	(0.66)

XML

Other Financial Statement Details (Tables)

3 Months Ended

Mar. 30, 2024

Other Financial Statement Details [Abstract]

Schedule of Inventory, Current [Table Text Block]

(In Millions)	Mar 30, 2024		Dec 30, 2023
Raw materials	$	1,209	$	1,166
Work in process	6,560		6,203
Finished goods	3,725		3,758
Total inventories	$	11,494	$	11,127

Interest and Other, Net [Table Text Block]

	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Interest income	$	323	$	334
Interest expense	(258)		(193)
Other, net	80		—
Total interest and other, net	$	145	$	141

XML

Restructuring and Other Charges (Tables)

3 Months Ended

Mar. 30, 2024

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Other Charges

	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Employee severance and benefit arrangements	$	129	$	(39)
Litigation charges and other	—		77
Asset impairment charges	219		26
Total restructuring and other charges	$	348	$	64

XML

Income Taxes (Tables)

3 Months Ended

Mar. 30, 2024

Income Tax Disclosure [Abstract]

Schedule of Income before Income Tax, Provision for Income Tax and Effective Tax Rate

	Three Months Ended
(In Millions)	Mar 30, 2024			Apr 1, 2023
Income (loss) before taxes	$	(719)		$	(1,158)
Provision for (benefit from) taxes	$	(282)		$	1,610
Effective tax rate	39.2		%	(139.0)		%

XML

Investments (Tables)

3 Months Ended

Mar. 30, 2024

Investments, Debt and Equity Securities [Abstract]

Investments Classified by Contractual Maturity Date [Table Text Block]

The fair value of marketable debt investments, by contractual maturity, as of March 30, 2024, was as follows:

(In Millions)	Fair Value
Due in 1 year or less	$	5,579
Due in 1–2 years	2,457
Due in 2–5 years	6,915
Due after 5 years	433
Instruments not due at a single maturity date1	2,460
Total	$	17,844

1 Instruments not due at a single maturity date is comprised of money market fund deposits, which are classified as either short-term investments or cash and cash equivalents.

Investment [Table Text Block]

(In Millions)	Mar 30, 2024		Dec 30, 2023
Marketable equity securities1	$	1,471	$	1,194
Non-marketable equity securities	4,664		4,630
Equity method investments	4		5
Total	$	6,139	$	5,829

1    Approximately 90% of our marketable equity securities are subject to trading-volume or market-based restrictions, which limit the number of shares we may sell in a specified period of time, impacting our ability to liquidate these investments. Certain of the trading volume restrictions generally apply for as long as we own more than 1% of the outstanding shares. Market-based restrictions result from the rules of the respective exchange.

Gain (Loss) on Securities [Table Text Block]

The components of gains (losses) on equity investments, net for each period were as follows:

	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Ongoing mark-to-market adjustments on marketable equity securities	$	(91)	$	188
Observable price adjustments on non-marketable equity securities	24		10
Impairment charges	(69)		(36)
Sale of equity investments and other1	341		7
Total gains (losses) on equity investments, net	$	205	$	169

1 Sale of equity investments and other includes initial fair value adjustments recorded upon a security becoming marketable, realized gains (losses) on sales of non-marketable equity investments and equity method investments, and our share of equity method investee gains (losses) and distributions.

XML

Fair Value (Tables)

3 Months Ended

Mar. 30, 2024

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis

	Mar 30, 2024								Dec 30, 2023
	Fair Value Measured and Recorded at Reporting Date Using								Fair Value Measured and Recorded at Reporting Date Using
(In Millions)	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Assets
Cash equivalents:
Corporate debt	$	—	$	231	$	—	$	231	$	—	$	769	$	—	$	769
Financial institution instruments¹	2,438		787		—		3,225		2,241		835		—		3,076
Reverse repurchase agreements	—		2,370		—		2,370		—		2,554		—		2,554
Short-term investments:
Corporate debt	—		6,298		—		6,298		—		6,951		—		6,951
Financial institution instruments¹	22		3,777		—		3,799		33		4,215		—		4,248
Government debt²	—		4,291		—		4,291		—		6,756		—		6,756
Other current assets:
Derivative assets	34		739		—		773		366		809		—		1,175
Marketable equity securities	1,471		—		—		1,471		1,194		—		—		1,194
Other long-term assets:
Derivative assets	—		6		—		6		—		21		—		21
Total assets measured and recorded at fair value	$	3,965	$	18,499	$	—	$	22,464	$	3,834	$	22,910	$	—	$	26,744
Liabilities
Other accrued liabilities:
Derivative liabilities	$	—	$	375	$	118	$	493	$	—	$	541	$	99	$	640
Other long-term liabilities:
Derivative liabilities	—		611		—		611		—		479		—		479
Total liabilities measured and recorded at fair value	$	—	$	986	$	118	$	1,104	$	—	$	1,020	$	99	$	1,119

1Level 1 investments consist of money market funds. Level 2 investments consist primarily of certificates of deposit, time deposits, commercial paper, notes and bonds issued by financial institutions.

2Level 2 investments consist primarily of non-US government debt.

XML

Derivative Financial Instruments (Tables)

3 Months Ended

Mar. 30, 2024

Derivative [Line Items]

Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]

Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows: 

(In Millions)	Mar 30, 2024		Dec 30, 2023
Foreign currency contracts	$	27,942	$	30,064
Interest rate contracts	18,611		18,363
Other	2,507		2,103
Total	$	49,060	$	50,530

The total notional amount of outstanding pay-variable, receive-fixed interest rate swaps was $12.0 billion as of March 30, 2024 and December 30, 2023.

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]

Fair Value of Derivative Instruments in the Consolidated Condensed Balance Sheets

	Mar 30, 2024				Dec 30, 2023
(In Millions)	Assets1		Liabilities2		Assets1		Liabilities2
Derivatives designated as hedging instruments:
Foreign currency contracts3	$	69	$	307	$	255	$	142
Interest rate contracts	—		723		—		578
Total derivatives designated as hedging instruments	$	69	$	1,030	$	255	$	720
Derivatives not designated as hedging instruments:
Foreign currency contracts3	$	391	$	65	$	314	$	363
Interest rate contracts	285		9		261		36
Equity contracts	34		—		366		—
Total derivatives not designated as hedging instruments	$	710	$	74	$	941	$	399
Total derivatives	$	779	$	1,104	$	1,196	$	1,119

1Derivative assets are recorded as other assets, current and long-term.

2Derivative liabilities are recorded as other liabilities, current and long-term.

3A substantial majority of these instruments mature within 12 months.

The amounts recorded on the Consolidated Condensed Balance Sheets related to cumulative basis adjustments for fair value hedges for each period were as follows:

Line Item in the Consolidated Condensed Balance Sheets in Which the Hedged Item is Included	Carrying Amount of the Hedged Item Assets/(Liabilities)				Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount Assets/(Liabilities)
(In Millions)	Mar 30, 2024		Dec 30, 2023		Mar 30, 2024		Dec 30, 2023
Long-term debt	$	(11,275)	$	(11,419)	$	722	$	578

Offsetting Assets [Table Text Block]

Agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows:

	Mar 30, 2024
							Gross Amounts Not Offset in the Balance Sheet
(In Millions)	Gross Amounts Recognized		Gross Amounts Offset in the Balance Sheet		Net Amounts Presented in the Balance Sheet		Financial Instruments		Cash and Non-Cash Collateral Received or Pledged		Net Amount
Assets:
Derivative assets subject to master netting arrangements	$	632	$	—	$	632	$	(350)	$	(282)	$	—
Reverse repurchase agreements	2,370		—		2,370		—		(2,370)		—
Total assets	$	3,002	$	—	$	3,002	$	(350)	$	(2,652)	$	—
Liabilities:
Derivative liabilities subject to master netting arrangements	$	1,097	$	—	$	1,097	$	(350)	$	(620)	$	127
Total liabilities	$	1,097	$	—	$	1,097	$	(350)	$	(620)	$	127

	Dec 30, 2023
							Gross Amounts Not Offset in the Balance Sheet
(In Millions)	Gross Amounts Recognized		Gross Amounts Offset in the Balance Sheet		Net Amounts Presented in the Balance Sheet		Financial Instruments		Cash and Non-Cash Collateral Received or Pledged		Net Amount
Assets:
Derivative assets subject to master netting arrangements	$	1,047	$	—	$	1,047	$	(617)	$	(430)	$	—
Reverse repurchase agreements	2,554		—		2,554		—		(2,554)		—
Total assets	$	3,601	$	—	$	3,601	$	(617)	$	(2,984)	$	—
Liabilities:
Derivative liabilities subject to master netting arrangements	$	1,111	$	—	$	1,111	$	(617)	$	(399)	$	95
Total liabilities	$	1,111	$	—	$	1,111	$	(617)	$	(399)	$	95

Offsetting Liabilities [Table Text Block]

Agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows:

	Mar 30, 2024
							Gross Amounts Not Offset in the Balance Sheet
(In Millions)	Gross Amounts Recognized		Gross Amounts Offset in the Balance Sheet		Net Amounts Presented in the Balance Sheet		Financial Instruments		Cash and Non-Cash Collateral Received or Pledged		Net Amount
Assets:
Derivative assets subject to master netting arrangements	$	632	$	—	$	632	$	(350)	$	(282)	$	—
Reverse repurchase agreements	2,370		—		2,370		—		(2,370)		—
Total assets	$	3,002	$	—	$	3,002	$	(350)	$	(2,652)	$	—
Liabilities:
Derivative liabilities subject to master netting arrangements	$	1,097	$	—	$	1,097	$	(350)	$	(620)	$	127
Total liabilities	$	1,097	$	—	$	1,097	$	(350)	$	(620)	$	127

	Dec 30, 2023
							Gross Amounts Not Offset in the Balance Sheet
(In Millions)	Gross Amounts Recognized		Gross Amounts Offset in the Balance Sheet		Net Amounts Presented in the Balance Sheet		Financial Instruments		Cash and Non-Cash Collateral Received or Pledged		Net Amount
Assets:
Derivative assets subject to master netting arrangements	$	1,047	$	—	$	1,047	$	(617)	$	(430)	$	—
Reverse repurchase agreements	2,554		—		2,554		—		(2,554)		—
Total assets	$	3,601	$	—	$	3,601	$	(617)	$	(2,984)	$	—
Liabilities:
Derivative liabilities subject to master netting arrangements	$	1,111	$	—	$	1,111	$	(617)	$	(399)	$	95
Total liabilities	$	1,111	$	—	$	1,111	$	(617)	$	(399)	$	95

Not Designated as Hedging Instrument [Member]

Derivative [Line Items]

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]

The effects of derivative instruments not designated as hedging instruments on the Consolidated Condensed Statements of Income for each period were as follows:

		Three Months Ended
(In Millions)	Location of Gains (Losses) Recognized in Income on Derivatives	Mar 30, 2024		Apr 1, 2023
Foreign currency contracts	Interest and other, net	$	346	$	1
Interest rate contracts	Interest and other, net	117		(34)
Other	Various	137		115
Total		$	600	$	82

Interest and other, net [Member] | Fair Value Hedging

Derivative [Line Items]

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]

The effects of derivative instruments designated as fair value hedges, recognized in interest and other, net for each period were as follows:

	Gains (Losses) on Derivatives Recognized in Consolidated Condensed Statements of Income
	Three Months Ended
(In Millions)	Mar 30, 2024		Apr 1, 2023
Interest rate contracts	$	(144)	$	192
Hedged items	144		(192)
Total	$	—	$	—

XML

Operating Segments - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Segment Reporting Information [Line Items]
Revenue from external customers	$ 12,724	$ 11,715
Goodwill impairment loss	222
Operating segments
Segment Reporting Information [Line Items]
Revenue from external customers	17,077	16,428
Operating segments | Intel Foundry
Segment Reporting Information [Line Items]
Revenue from external customers	4,369	4,831
Operating segments | Intel Foundry | Assembly And Test
Segment Reporting Information [Line Items]
Revenue from external customers	27	118
Operating segments | Other
Segment Reporting Information [Line Items]
Revenue from external customers	$ 194	$ 166

XML

Operating Segments - Net Revenue and Operating Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Segment Reporting Information [Line Items]
Net revenue	$ 12,724	$ 11,715
Operating income (loss)	(1,069)	(1,468)
Operating segments
Segment Reporting Information [Line Items]
Net revenue	17,077	16,428
Operating income (loss)	625	(880)
Operating segments | Intel Products
Segment Reporting Information [Line Items]
Net revenue	11,933	10,157
Operating income (loss)	3,311	1,133
Operating segments | Client Computing
Segment Reporting Information [Line Items]
Net revenue	7,533	5,767
Operating income (loss)	2,645	1,180
Operating segments | Client Computing | Desktop
Segment Reporting Information [Line Items]
Net revenue	2,461	1,879
Operating segments | Client Computing | Notebook
Segment Reporting Information [Line Items]
Net revenue	4,681	3,407
Operating segments | Client Computing | Other
Segment Reporting Information [Line Items]
Net revenue	391	481
Operating segments | Datacenter and AI
Segment Reporting Information [Line Items]
Net revenue	3,036	2,901
Operating income (loss)	482	22
Operating segments | Network and Edge
Segment Reporting Information [Line Items]
Net revenue	1,364	1,489
Operating income (loss)	184	(69)
Operating segments | Intel Foundry
Segment Reporting Information [Line Items]
Net revenue	4,369	4,831
Operating income (loss)	(2,474)	(2,360)
Operating segments | All Other
Segment Reporting Information [Line Items]
Net revenue	775	1,440
Operating income (loss)	(212)	347
Operating segments | Altera
Segment Reporting Information [Line Items]
Net revenue	342	816
Operating income (loss)	(39)	290
Operating segments | Mobileye
Segment Reporting Information [Line Items]
Net revenue	239	458
Operating income (loss)	(68)	123
Operating segments | Other
Segment Reporting Information [Line Items]
Net revenue	194	166
Operating income (loss)	(105)	(66)
Intersegment eliminations
Segment Reporting Information [Line Items]
Net revenue	(4,353)	(4,713)
Operating income (loss)	494	456
Corporate unallocated expenses
Segment Reporting Information [Line Items]
Operating income (loss)	$ (2,188)	$ (1,044)

XML

Operating Segments - Corporate Unallocated Expenses (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Segment Reporting Information [Line Items]
Restructuring and other charges	$ (348)	$ (64)
Operating income (loss)	(1,069)	(1,468)
Corporate unallocated expenses
Segment Reporting Information [Line Items]
Acquisition-related adjustments	(265)	(371)
Share-based compensation	(1,179)	(739)
Restructuring and other charges	(348)	(64)
Other	(396)	130
Operating income (loss)	$ (2,188)	$ (1,044)

XML

Non-Controlling Interests - Components (Details) - USD ($) $ in Millions	Mar. 30, 2024	Dec. 30, 2023
Noncontrolling Interest [Line Items]
Non-controlling interest	$ 4,783	$ 4,375
Arizona Fab LLC
Noncontrolling Interest [Line Items]
Non-controlling interest	2,760	2,359
Mobileye
Noncontrolling Interest [Line Items]
Non-controlling interest	1,854	1,838
IMS Nanofabrication
Noncontrolling Interest [Line Items]
Non-controlling interest	$ 169	$ 178
Arizona Fab LLC
Noncontrolling Interest [Line Items]
Non-controlling interest percent held by parent	49.00%	49.00%
Mobileye
Noncontrolling Interest [Line Items]
Non-controlling interest percent held by parent	12.00%	12.00%
IMS Nanofabrication
Noncontrolling Interest [Line Items]
Non-controlling interest percent held by parent	32.00%	32.00%

XML

Non-Controlling Interests - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended	12 Months Ended
	Mar. 30, 2024	Dec. 30, 2023
Noncontrolling Interest [Line Items]
Assets	$ 192,733	$ 191,572
Variable Interest Entity, Primary Beneficiary | Asset Pledged as Collateral
Noncontrolling Interest [Line Items]
Assets	5,600	$ 4,800
Mobileye
Noncontrolling Interest [Line Items]
Conversion of stock, shares converted (in shares)		38,500,000
Conversion of stock, shares converted, percentage of outstanding shares		0.05
Shares issued per share (in dollars per share)		$ 42
Net proceeds		$ 1,600
Mobileye | Capital in excess of par value
Noncontrolling Interest [Line Items]
Net proceeds from partner contributions		663
IMS Nanofabrication
Noncontrolling Interest [Line Items]
Proceeds from sales of subsidiary shares		1,400
IMS Nanofabrication | Capital in excess of par value
Noncontrolling Interest [Line Items]
Net proceeds from partner contributions		$ 958
Semiconductor Co-Investment Program, Construction Costs | Intel and Brookfield
Noncontrolling Interest [Line Items]
Unrecognized commitment	$ 29,000
Arizona Fab LLC
Noncontrolling Interest [Line Items]
Percentage of factory output with the right to purchase	100.00%
IMS Nanofabrication
Noncontrolling Interest [Line Items]
Ownership percentage sold		32.00%
IMS Nanofabrication | Bain Capital Special Situations
Noncontrolling Interest [Line Items]
Ownership percentage sold		20.00%
IMS Nanofabrication | TSMC
Noncontrolling Interest [Line Items]
Ownership percentage sold		10.00%

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Earnings Per Share [Abstract]
Net income (loss)	$ (437)	$ (2,768)
Less: Net income (loss) attributable to non-controlling interests	(56)	(10)
Net income (loss) attributable to Intel	$ (381)	$ (2,758)
Weighted average shares of common stock outstanding—basic	4,242	4,154
Weighted average shares of common stock outstanding—diluted	4,242	4,154
Earnings per share - Basic (in dollars per share)	$ (0.09)	$ (0.66)
Earnings per share - Diluted (in dollars per share)	$ (0.09)	$ (0.66)

XML

Other Financial Statement Details - Accounts Receivable (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Other Financial Statement Details [Abstract]
Accounts receivable sold	$ 500	$ 500

XML

Other Financial Statement Details - Inventories (Details) - USD ($) $ in Millions	Mar. 30, 2024	Dec. 30, 2023
Other Financial Statement Details [Abstract]
Raw materials	$ 1,209	$ 1,166
Work in process	6,560	6,203
Finished goods	3,725	3,758
Total inventories	$ 11,494	$ 11,127

XML

Other Financial Statement Details - Other Accrued Liabilities (Details) - USD ($) $ in Billions	Mar. 30, 2024	Dec. 30, 2023
Other Financial Statement Details [Abstract]
Deferred compensation	$ 2.9	$ 2.9

XML

Other Financial Statement Details - Interest and Other, Net (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Other Financial Statement Details [Abstract]
Interest income	$ 323	$ 334
Interest expense	(258)	(193)
Other, net	80	0
Total interest and other, net	145	141
Interest Costs Capitalized	$ (363)	$ (363)

XML

Other Financial Statement Details - Property, Plant and Equipment (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Dec. 30, 2023
Change in Accounting Estimate [Line Items]
Increase to gross margin	$ 5,217	$ 4,008
Decrease in R&D expenses	(4,382)	$ (4,109)
Decrease in ending inventory	$ (11,494)		$ (11,127)

XML

Restructuring and Other Charges - Components (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Restructuring and Related Activities [Abstract]
Employee severance and benefit arrangements	$ 129	$ (39)
Litigation charges and other	0	77
Asset impairment charges	219	26
Restructuring and other charges	$ 348	$ 64

XML

Restructuring and Other Charges - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Loss Contingencies [Line Items]
Restructuring and other charges	$ 348	$ 55
Goodwill impairment loss	222
Charge (benefit) recorded in litigation charges and other	0	$ 77
2022 Restructuring Program
Loss Contingencies [Line Items]
Restructuring and other charges	$ 129

XML

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Income Tax Disclosure [Abstract]
Income (loss) before taxes	$ (719)	$ (1,158)
Provision for (benefit from) taxes	$ (282)	$ 1,610
Effective tax rate	39.20%	(139.00%)

XML

Investments - Short-term Investments (Details) - USD ($)	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Dec. 30, 2023
Schedule Of Trading Securities And Other Trading Assets [Line Items]
Debt Securities, Realized Gain (Loss)	$ 307,000,000	$ 90,000,000
Debt Securities, Available-for-sale, Amortized Cost	4,000,000,000		$ 4,700,000,000
Available-for-sale Securities
Schedule Of Trading Securities And Other Trading Assets [Line Items]
Derivative, Amount of Hedged Item	13,800,000,000		$ 17,100,000,000
Unrealized Gain (Loss) on Derivatives	$ 345,000,000	$ 102,000,000

XML

Investments - Available-for-Sale Debt Investments (Details) $ in Millions	Mar. 30, 2024 USD ($)
Investments, Debt and Equity Securities [Abstract]
Due in 1 year or less	$ 5,579
Due in 1–2 years	2,457
Due in 2–5 years	6,915
Due after 5 years	433
Instruments not due at a single maturity date	2,460
Debt Securities, Available-for-Sale, Total	$ 17,844

XML

Investments - Equity Investments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Dec. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	$ 1,471		$ 1,194
Cost Method Investments	4,664		4,630
Equity Method Investments	4		5
Equity Investments	$ 6,139		$ 5,829
Marketable equity securities subject to trading-volume or market-based restrictions	90.00%
Marketable equity securities threshold percentage of shares owned resulting in trading volume restrictions	1.00%
Mark to market on marketable equity securities1	$ (91)	$ 188
Observable price adjustments on non-marketable	24	10
Impairments	(69)	(36)
Other Net Equity Investments	341	7
Gain (Loss) on Investments	$ 205	$ 169

XML

Investments - Equity Investments, Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Schedule of Equity Method Investments [Line Items]
Special dividend recognized in sale of equity investments and other	$ 341	$ 7

XML

Investments - Bejing Unisoc Technology (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Schedule of Investments [Line Items]
Gains (losses) on equity investments, net	$ 205	$ 169

XML

Divestitures (Details) - USD ($) $ in Millions	Mar. 30, 2024	Dec. 30, 2023
Business Acquisition [Line Items]
Receivable recorded in other current assets	$ 6,480	$ 3,706
NAND Memory Business Divestiture | Affiliated Entity
Business Acquisition [Line Items]
Receivable recorded in other current assets	150	$ 145
NAND Memory Business
Business Acquisition [Line Items]
Noncurrent receivable	2,000
Maximum exposure annually	500
Maximum exposure	$ 1,500

XML

Borrowings - Narrative (Details) - USD ($)	3 Months Ended
	Apr. 01, 2023	Mar. 30, 2024	Dec. 30, 2023
Debt Instrument [Line Items]
Commercial paper outstanding		$ 793,000,000	$ 0
Commercial Paper
Debt Instrument [Line Items]
Maximum borrowing capacity		10,000,000,000
Revolving Credit Facility | Variable Rate Revolving Credit Facility
Debt Instrument [Line Items]
Term of debt	5 years
Maximum borrowing capacity	$ 7,000,000,000		5,000,000,000
Variable rate revolving credit facility		0
Senior Notes
Debt Instrument [Line Items]
Face amount of debt		2,600,000,000
Line of Credit | Credit Facility Agreement
Debt Instrument [Line Items]
Term of debt	364 days
Maximum borrowing capacity	$ 8,000,000,000		$ 5,000,000,000
Variable rate revolving credit facility		$ 0

XML

Fair Value (Detail) - USD ($) $ in Millions	Mar. 30, 2024	Dec. 30, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	$ 2,370	$ 2,554
Derivative assets, Fair Value Disclosure	632	1,047
Derivative liabilities, Fair Value Disclosure	1,097	1,111
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	22,464	26,744
Liabilities, Fair Value Disclosure	1,104	1,119
Fair Value, Nonrecurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Grants & loans Receivable, Reverse repurchase agreements, CV	666	559
Short-term and Long-term Debt, Fair Value	48,700	47,600
Marketable Equity Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1,471	1,194
Cash Equivalents [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	2,370	2,554
Cash Equivalents [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	231	769
Cash Equivalents [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	3,225	3,076
Short-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	6,298	6,951
Short-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	3,799	4,248
Short-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	4,291	6,756
Other Current Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	773	1,175
Other Long-Term Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	6	21
Other Accrued Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	493	640
Other Long-Term Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	611	479
Level 1 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	3,965	3,834
Liabilities, Fair Value Disclosure	0	0
Level 1 [Member] | Marketable Equity Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1,471	1,194
Level 1 [Member] | Cash Equivalents [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	0	0
Level 1 [Member] | Cash Equivalents [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] | Cash Equivalents [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	2,438	2,241
Level 1 [Member] | Short-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] | Short-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	22	33
Level 1 [Member] | Short-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] | Other Current Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	34	366
Level 1 [Member] | Other Long-Term Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	0	0
Level 1 [Member] | Other Accrued Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	0	0
Level 1 [Member] | Other Long-Term Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	0	0
Level 2 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	18,499	22,910
Liabilities, Fair Value Disclosure	986	1,020
Level 2 [Member] | Marketable Equity Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 2 [Member] | Cash Equivalents [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	2,370	2,554
Level 2 [Member] | Cash Equivalents [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	231	769
Level 2 [Member] | Cash Equivalents [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	787	835
Level 2 [Member] | Short-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	6,298	6,951
Level 2 [Member] | Short-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	3,777	4,215
Level 2 [Member] | Short-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	4,291	6,756
Level 2 [Member] | Other Current Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	739	809
Level 2 [Member] | Other Long-Term Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	6	21
Level 2 [Member] | Other Accrued Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	375	541
Level 2 [Member] | Other Long-Term Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	611	479
Level 3 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	0	0
Liabilities, Fair Value Disclosure	118	99
Level 3 [Member] | Marketable Equity Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Cash Equivalents [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	0	0
Level 3 [Member] | Cash Equivalents [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Cash Equivalents [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Short-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Short-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Short-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Other Current Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	0	0
Level 3 [Member] | Other Long-Term Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	0	0
Level 3 [Member] | Other Accrued Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	118	99
Level 3 [Member] | Other Long-Term Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	$ 0	$ 0

XML

Derivative Financial Instruments (Detail) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Dec. 30, 2023
Notional Disclosures [Abstract]
Notional amount	$ 49,060		$ 50,530
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	632		1,047
Derivative Assets Subject to Master Netting Arrangements, Gross Amounts Offset in the Balance Sheet	0		0
Derivative Assets Subject to Master Netting Arrangements, Net Amount Presented in the Balance Sheet	632		1,047
Derivative Assets, Financial Instruments Not Offset in the Balance Sheet	(350)		(617)
Derivative Assets, Cash Collateral Not Offset in the Balance Sheet	(282)		(430)
Derivative Assets Subject to Master Netting Arrangements, Net Amount	0		0
Reverse Repurchase Agreements, Gross Amounts Recognized	2,370		2,554
Reverse Repurchase Agreements, Gross Amounts Offset In The Balance Sheet	0		0
Reverse Repurchase Agreements, Net Amount Presented in the Balance Sheet	2,370		2,554
Reverse Repurchase Agreements, Financial Instruments Not Offset in the Balance Sheet	0		0
Reverse Repurchase Agreements, Cash Collateral Not Offset in the Balance Sheet	(2,370)		(2,554)
Reverse Repurchase Agreements, Net Amount	0		0
Total Assets, Gross Amounts Recognized	3,002		3,601
Total Assets, Gross Amounts Offset in the Balance Sheet	0		0
Total Assets, Net Amounts Presented in the Balance Sheet	3,002		3,601
Total Assets, Financial Instruments, Not Offset in the Balance Sheet	(350)		(617)
Total Assets, Cash and Non Cash Collateral, Not Offset in the Balance Sheet	(2,652)		(2,984)
Total Assets, Net Amount	0		0
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	1,097		1,111
Derivative Liabilities Subject to Master Netting Arrangements, Gross Amounts Offset in the Balance Sheet	0		0
Derivative Liabilities Subject to Master Netting Arrangements, Net Amount Presented in the Balance Sheet	1,097		1,111
Derivative Liabilities, Financial Instruments Not Offset in the Balance Sheet	(350)		(617)
Derivative Liabilities, Cash Collateral Not Offset in the Balance Sheet	(620)		(399)
Derivative Liabilities Subject to Master Netting Arrangements, Net Amount	127		95
Effect of Fair Value Hedges on Results of Operations [Abstract]
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	144	$ (192)
Net Change In Unrealized Gain (Loss) Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge	0	0
Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	779		1,196
Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	1,104		1,119
Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	69		255
Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	1,030		720
Not Designated as Hedging Instrument [Member]
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	600	82
Not Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	710		941
Not Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	74		399
Foreign currency contracts
Notional Disclosures [Abstract]
Notional amount	27,942		30,064
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net [Abstract]
Before-tax net gains (losses) attributed to cash flow hedges, recognized in other comprehensive income (loss)	(431)	53
Foreign currency contracts | Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	69		255
Foreign currency contracts | Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	307		142
Foreign currency contracts | Not Designated as Hedging Instrument [Member]
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	346	1
Foreign currency contracts | Not Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	391		314
Foreign currency contracts | Not Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	65		363
Interest rate contracts
Notional Disclosures [Abstract]
Notional amount	18,611		18,363
Effect of Fair Value Hedges on Results of Operations [Abstract]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	(144)	192
Interest rate contracts | Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	0		0
Interest rate contracts | Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	723		578
Interest rate contracts | Not Designated as Hedging Instrument [Member]
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	117	(34)
Interest rate contracts | Not Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	285		261
Interest rate contracts | Not Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	9		36
Other
Notional Disclosures [Abstract]
Notional amount	2,507		2,103
Other | Not Designated as Hedging Instrument [Member]
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	137	$ 115
Other | Not Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	34		366
Other | Not Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	0		0
Interest Rate Swap | Long-term Debt | Fair Value Hedging
Derivative [Line Items]
Derivative, Amount of Hedged Item	12,000
Derivative, Fair Value, Net	(11,275)		(11,419)
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	$ 722		$ 578

XML

Contingencies (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Dec. 30, 2023
Loss Contingencies [Line Items]
Litigation charges and other	$ 0	$ 77
Finance lease prepayments	0	$ 15
EC Fine
Loss Contingencies [Line Items]
Estimated Litigation Liability	401
VLSI Litigation
Loss Contingencies [Line Items]
Estimated Litigation Liability	$ 1,000
Arizona Fab LLC
Loss Contingencies [Line Items]
Non-controlling interest percent held by parent	49.00%		49.00%